home.aspx
 

RESOURCES


   
Developing Neuroprotective Therapies: Defending the Nervous System from Damage DEVELOPING NEUROPROTECTIVE THERAPIES: DEFENDING THE NERVOUS SYSTEM FROM DAMAGE

blog article

Aug 17, 2018

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners recently announced the launch of Magnolia Neurosciences Corporation – a biopharmaceutical company advancing a new class of neuroprotective medicines. To learn more about Magnolia Neurosciences, we spoke to ...

Read More

Is it safe to mix aspirin and ibuprofen? IS IT SAFE TO MIX ASPIRIN AND IBUPROFEN?

blog article

Aug 16, 2018

Taking aspirin and ibuprofen at the same time can cause side effects. The safety of mixing these drugs depends on the reasons why people are taking them. Aspirin and ibuprofen are both pain relievers from the same family of medicines known as non-steroidal anti-inflammatory drugs or NSAIDs. Because ...

Read More

What are the natural ways to prevent prostate cancer? WHAT ARE THE NATURAL WAYS TO PREVENT PROSTATE CANCER?

blog article

Aug 16, 2018

There is no single best way to prevent prostate cancer, but several natural methods can help. These include maintaining a healthful weight, exercising, and eating plenty of fruits and vegetables. After skin cancer, prostate cancer is the type most common among American men, according to the Centers ...

Read More

New chemical causes deadly brain cancer to self-destruct NEW CHEMICAL CAUSES DEADLY BRAIN CANCER TO SELF-DESTRUCT

blog article

Aug 16, 2018

Scientists have discovered a chemical compound that cuts off the "energy supply" to glioblastoma cells, making them self-destruct.  A newly discovered chemical may improve brain cancer survival. A glioblastoma is a deadly form of brain cancer. Glioblastoma tumors emerge from the ...

Read More

Why cannabis relieves IBD symptoms WHY CANNABIS RELIEVES IBD SYMPTOMS

blog article

Aug 14, 2018

New research, published in the Journal of Clinical Investigation, reveals the molecular mechanism that explains why cannabis could help treat inflammatory bowel disease. Inflammatory bowel disease (IBD) is an umbrella term that describes inflammatory conditions affecting the gastrointestinal tract, ...

Read More

New technique treats prostate cancer in just five radiotherapy sessions NEW TECHNIQUE TREATS PROSTATE CANCER IN JUST FIVE RADIOTHERAPY SESSIONS

blog article

Aug 14, 2018

A new clinical trial shows the benefits of an innovative form of radiation therapy, which delivers the radiation in only five sessions instead of the usual 37. The National Cancer Institute (NCI) estimates that prostate cancer affects over 160,000 people in the United States. In 2018, almost 30,000 ...

Read More

Highly Effective and Selective Molecule Developed to Fight Malaria HIGHLY EFFECTIVE AND SELECTIVE MOLECULE DEVELOPED TO FIGHT MALARIA

blog article

Aug 13, 2018

A novel laboratory-synthesized molecule is a strong candidate for the development of a new antimalarial drug. The possibility of a new drug offers hope for thousands of patients infected by Plasmodium falciparum, one of the parasites that cause malaria, above all because tests have proved that the m...

Read More

3D Electron Microscopy of Synapse Building 3D ELECTRON MICROSCOPY OF SYNAPSE BUILDING

blog article

Aug 13, 2018

New research from a team led by Marshall University scientist W. Christopher Risher, Ph.D., reveals novel molecular insights into how multiple cell types drive the formation and maturation of brain circuits. The brain is a highly complex organ that enables us to think, remember, move and perform sim...

Read More

Glaucoma May Be An Autoimmune Disease GLAUCOMA MAY BE AN AUTOIMMUNE DISEASE

blog article

Aug 10, 2018

Glaucoma, a disease that afflicts nearly 70 million people worldwide, is something of a mystery despite its prevalence. Little is known about the origins of the disease, which damages the retina and optic nerve and can lead to blindness. A new study from MIT and Massachusetts Eye and Ear has found t...

Read More

What Might Explain the Unhappiness Epidemic? WHAT MIGHT EXPLAIN THE UNHAPPINESS EPIDEMIC?

blog article

Aug 08, 2018

Although measures of teen and adult happiness dropped during the high unemployment rates of the Great Recession, it didn’t rebound when the economy started to improve. We’d all like to be a little happier. The problem is that much of what determines happiness is outside of our control. S...

Read More

AI Is a New Must for Medical Software AI IS A NEW MUST FOR MEDICAL SOFTWARE

blog article

Aug 08, 2018

It appears that artificial intelligence is an apple of discord in disruptive technologies. On the one hand, even those who create new products based on AI or implement it across their internal processes, are worried. “Artificial intelligence and robots will kill many jobs,” predicts Jack...

Read More

Cancer Cells vs Normal Cells CANCER CELLS VS NORMAL CELLS

blog article

Aug 08, 2018

Cancer is a complex genetic disease that is caused by specific changes to the genes in one cell or group of cells. These changes disrupt normal cell function – specifically affecting how a cell grows and divides. Cancer cells have more genetic changes compared to normal cells, however not all ...

Read More

Link between appendicitis and allergies discovered LINK BETWEEN APPENDICITIS AND ALLERGIES DISCOVERED

blog article

Aug 07, 2018

Children with allergies have a lower risk of developing complicated appendicitis, according to a new study from Lund University and Skåne University Hospital in Sweden. The findings, now published in JAMA Pediatrics, could pave the way for new diagnostic tools in the future. "In a study o...

Read More

Novel Approach Could Lead to Creation of New Thiophosphate-Based Nucleotide Drugs NOVEL APPROACH COULD LEAD TO CREATION OF NEW THIOPHOSPHATE-BASED NUCLEOTIDE DRUGS

blog article

Aug 07, 2018

Scientists at Scripps Research and Bristol-Myers Squibb have created a novel tool for precisely controlling the stereochemistry of thiophosphates, found in some promising new drugs that target genetic molecules and other disease targets. Called phosphorus-sulfur incorporation (PSI), the technology a...

Read More

ADHD medications: Of all available drugs, methylphenidate should be first option for short-term treatment in children ADHD MEDICATIONS: OF ALL AVAILABLE DRUGS, METHYLPHENIDATE SHOULD BE FIRST OPTION FOR SHORT-TERM TREATMENT IN CHILDREN

blog article

Aug 07, 2018

Of the drugs available for attention-deficit hyperactivity disorder (ADHD), the most effective and safe for short-term treatment is methylphenidate for children, and amphetamines for adults, according to the most comprehensive evidence yet from a network meta-analysis and systematic review comparing...

Read More

Learning More About Addiction Relapse LEARNING MORE ABOUT ADDICTION RELAPSE

blog article

Aug 06, 2018

Researchers studying cocaine addiction have managed to significantly reduce relapse rates in a preclinical model. To do so, a molecule called BDNF was delivered directly to a part of the brain that has a critical role in reward-seeking behavior, the nucleus accumbens, just before a rat model sought ...

Read More

pH imbalance in astrocytes may lead to Alzheimer’s disease PH IMBALANCE IN ASTROCYTES MAY LEAD TO ALZHEIMER’S DISEASE

blog article

Aug 06, 2018

Researchers have identified that a simple pH imbalance in astrocytes could be the root of Alzheimer’s disease (AD). Scientists at Johns Hopkins Medicine said they have found new evidence in lab-grown mice brain cells that an imbalance in acid-alkaline chemistry in the endosomes may be a cause ...

Read More

New drug may improve liver cancer therapy NEW DRUG MAY IMPROVE LIVER CANCER THERAPY

blog article

Aug 06, 2018

Researchers from many international institutions have teamed up to design a more effective drug for liver cancer therapy. Their compound may help improve survival rates and reduce adverse effects. The researcher working in the lab. If it is not caught early, this means that people who have been diag...

Read More

Belly fat linked to cognitive decline BELLY FAT LINKED TO COGNITIVE DECLINE

blog article

Aug 06, 2018

In the largest study of its type, researchers conclude that having higher levels of belly fat in old age is correlated with a reduction in cognitive function. Dementias, including Alzheimer's, are a growing concern. As the average age of the population steadily rises, their prevalence increases....

Read More

Agitation in dementia: Are drugs the best treatment? AGITATION IN DEMENTIA: ARE DRUGS THE BEST TREATMENT?

blog article

Aug 05, 2018

A common symptom among people with dementia is agitation, which can affect their and their carers' well-being. Dementia experts conducted a new study and found the most effective means of addressing agitation. In a paper that is now published in the journal International Psychogeriatrics, expert...

Read More

Alzheimer’s Drug May Stop Disease If Used Symptoms Develop ALZHEIMER’S DRUG MAY STOP DISEASE IF USED SYMPTOMS DEVELOP

blog article

Aug 01, 2018

About 50 percent of people who reach the age of 85 will develop Alzheimer’s disease. Most will die within about five years of exhibiting the hallmark symptoms of the disease severe memory loss and a precipitous decline in cognitive function. But the molecular processes that lead to the disease...

Read More

Artificial Intelligence System Designs Drugs From Scratch ARTIFICIAL INTELLIGENCE SYSTEM DESIGNS DRUGS FROM SCRATCH

blog article

Aug 01, 2018

An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates. The system is called Reinforcement...

Read More

New blood test may someday help guide the best treatment for aggressive prostate cancer NEW BLOOD TEST MAY SOMEDAY HELP GUIDE THE BEST TREATMENT FOR AGGRESSIVE PROSTATE CANCER

blog article

Aug 01, 2018

Tumors that spread, or metastasize, in the body shed cells into the blood that doctors can scrutinize for insights into what a patient’s cancer might do. Analyzing these so-called circulating tumor cell  (CTC) isn’t part of routine care yet, in part because they’re so har...

Read More

The top 5 vaccine companies by 2017 revenue THE TOP 5 VACCINE COMPANIES BY 2017 REVENUE

blog article

Aug 01, 2018

Even in an industry dominated by a few huge companies, disruption happens sometimes and 2017 was one of those times. GlaxoSmithKline surpassed Merck to top the vaccine industry by sales, generating $7 billion compared to Merck's $6.5 billion. It stands to be a long-term switch, too; analysts pre...

Read More

Effective Drug For Disorders of Copper Metabolism EFFECTIVE DRUG FOR DISORDERS OF COPPER METABOLISM

blog article

Aug 01, 2018

According to a paper in the Proceedings of the National Academy of Sciences, a research team led by Dr. Vishal Gohil of Texas A&M AgriLife Research in College Station has now offered more targeted treatment options for individuals with defects in copper metabolism. The paper reports on an invest...

Read More

Can cell phone use cause ADHD? CAN CELL PHONE USE CAUSE ADHD?

blog article

Jul 31, 2018

Anyone who has spent any time around teens, and seen the way they often seem surgically attached to their phones, has likely wondered: is all that time on the phone affecting their brains? Researchers from California studied the digital media use of more than 2,500 high school students who did not h...

Read More

Pill Approved For Endometriosis Treatment PILL APPROVED FOR ENDOMETRIOSIS TREATMENT

blog article

Jul 31, 2018

A first drug, by the name of Elagolix, to treat for endometriosis-related pain, has recently become approved by the US Food and Drug Administration. Endometriosis is caused by uterine tissue moving to another part of the body, usually around the pelvis. The pain, which affects one in ten young women...

Read More

DNA For Drug Development? DNA FOR DRUG DEVELOPMENT?

blog article

Jul 31, 2018

Genetic data of individuals who were customers of DNA testing service for the purpose of understanding their ancestry and genetic history, such as the company 23andME, could now be utilized for the development of new drugs. 23andMe, the home DNA testing service, announced a 4-year deal with pharmace...

Read More

Molecule deficiency may help diagnose severe depression MOLECULE DEFICIENCY MAY HELP DIAGNOSE SEVERE DEPRESSION

blog article

Jul 31, 2018

A new study, published in the journal PNAS, suggests that a diagnostic blood test for depression may soon be on the horizon. The new research shows that treatment-resistant depression is characterized by reduced blood levels of a specific molecule. According to the most recent estimates from the Nat...

Read More

Pancreatic cancer: Cannabis compound may boost survival PANCREATIC CANCER: CANNABIS COMPOUND MAY BOOST SURVIVAL

blog article

Jul 31, 2018

Pancreatic cancer is a type of cancer that unfortunately has some of the lowest survival rates. A new study in mice suggests that one substance could help address this problem: cannabidiol, a naturally occurring cannabis compound. According to data from the National Cancer Institute (NCI), in the Un...

Read More

What are the symptoms of late stage bladder cancer? WHAT ARE THE SYMPTOMS OF LATE STAGE BLADDER CANCER?

blog article

Jul 30, 2018

It is difficult to remove stage 4 cancer from the body entirely. The main aim of treatment, therefore, is to give people the best possible quality of life. Doctors use staging to help diagnose cancer, plan treatment, and explain a person's outlook clearly. There are four stages, which people oft...

Read More

Mini-brains offer hope in search for new drugs for brain disorders MINI-BRAINS OFFER HOPE IN SEARCH FOR NEW DRUGS FOR BRAIN DISORDERS

blog article

Jul 30, 2018

Miniature brains grown in laboratory dishes could overcome some of the problems testing drugs on animals and help researchers identify new ways to treat very human, and incurable, conditions like Alzheimer’s disease and epilepsy. Most new drugs are developed and tested using mice as models. Ho...

Read More

Gender Disparity in Post Heart Attack Treatment GENDER DISPARITY IN POST HEART ATTACK TREATMENT

blog article

Jul 29, 2018

Every 40 seconds, someone in the United States has a heart attack, with 790,000 Americans having a heart attack every year. After a heart attack, heart damage can affect heart rhythm, pumping action, and blood circulation. Damage can increase the risk of another heart attack or other conditions such...

Read More

Parkinson PARKINSON'S GENE AFFECTS MORE PEOPLE THAN PREVIOUSLY THOUGHT

blog article

Jul 28, 2018

New research finds that a gene previously thought to affect only a small percentage of Parkinson's disease cases actually affects many more. The findings mean that treatments that are being developed for a small number of people may, in fact, benefit many more. Almost 1 million people in the Uni...

Read More

Psoriasis: Mediterranean diet may slow disease progression PSORIASIS: MEDITERRANEAN DIET MAY SLOW DISEASE PROGRESSION

blog article

Jul 27, 2018

A new study suggests that adhering to a Mediterranean diet may relieve the severity of psoriasis and slow its progression. Mediterranean salad on blue background Psoriasis is a chronic inflammatory disease that affects about 6.7 million adults in the United States, according to recent estimates. Som...

Read More

Side effects of painkillers are worse in Alzheimer SIDE EFFECTS OF PAINKILLERS ARE WORSE IN ALZHEIMER'S

blog article

Jul 27, 2018

A recent study demonstrates that pain relief drugs produce more pronounced side effects when taken by people with dementia. A second study uncovers why this might be the case. Older adult Alzheimer's care home. Dementia is a large and growing concern. Because it cannot be reversed, understanding...

Read More

Cannabinoids for Dementia CANNABINOIDS FOR DEMENTIA

blog article

Jul 26, 2018

One area of interest in the last year, as medical cannabis moves into the mainstream, is the use of cannabinoids for the treatment of dementia.  To be clear, many of the scientists or providers looking to cannabis or cannabinoid products are really looking at treating the symptoms associated wi...

Read More

New enzyme discovery may help improve drugs against cancer, diabetes and obesity NEW ENZYME DISCOVERY MAY HELP IMPROVE DRUGS AGAINST CANCER, DIABETES AND OBESITY

blog article

Jul 26, 2018

A new study reveals that several drugs for treating hematological cancers are less effective than expected in inhibiting a special enzyme. Researchers have also identified new lead compounds that could potentially improve existing treatments and pave the way for new drugs against diabetes and obesit...

Read More

Adapting drug discovery to Artificial Intelligence ADAPTING DRUG DISCOVERY TO ARTIFICIAL INTELLIGENCE

blog article

Jul 25, 2018

There is a need and opportunity to explore new drug discovery approaches that harness immense datasets (public and private), which have been built upon the successes and failures of the past to guide in-silico approaches to new therapies. Advances in genetics and molecular biology have revealed pote...

Read More

Fitness Trackers Helpful For Cancer Assessments FITNESS TRACKERS HELPFUL FOR CANCER ASSESSMENTS

blog article

Jul 25, 2018

A new study published in the journal Digital Medicine found that fitness trackers can be used as a valuable tool to only assess the quality of life but the daily functioning of cancer patients during the course of their treatment. The trackers, also called wearable activity monitors, include commerc...

Read More

Super-resolution Microscope Provides Insight Into Alzheimer SUPER-RESOLUTION MICROSCOPE PROVIDES INSIGHT INTO ALZHEIMER'S PLAQUES

blog article

Jul 25, 2018

Alzheimer’s disease impacts around 200,000 Americans; it is the country’s sixth leading cause of death. The disease is thought to begin affecting the brain ten to twenty years before it can be diagnosed, which is a serious treatment challenge. New work by scientists at Purdue University ...

Read More

Gottlieb Reshapes FDA to Elevate Centers, Streamline Policymaking GOTTLIEB RESHAPES FDA TO ELEVATE CENTERS, STREAMLINE POLICYMAKING

blog article

Jul 25, 2018

Most FDA commissioners look to leave their imprint on the agency by making structural changes that update the roles and functions of lead operations. After more than a year at the agency’s helm, Scott Gottlieb now proposes to flatten out FDA’s structure by having the Center directors rep...

Read More

Liver Disease Deaths Are Up in Young Adults LIVER DISEASE DEATHS ARE UP IN YOUNG ADULTS

blog article

Jul 25, 2018

It’s a fact that overuse of alcohol can cause liver problems. Cirrhosis of the liver is often the result of long-term alcoholism, but a new study of the data shows that liver disease is increasing in young adults, a group not generally seen as at risk. During the years 1999-2016 deaths from ci...

Read More

Can You Be Obese and Metabolically Healthy? CAN YOU BE OBESE AND METABOLICALLY HEALTHY?

blog article

Jul 24, 2018

Experts in the medical field, nutrition and fitness professionals and health educators all advise against the dangers of becoming overweight. They cite an "obesity epidemic," and it's true that health problems that can go along with obesity, such as hypertension, diabetes and cardiovas...

Read More

Measles are on the Move MEASLES ARE ON THE MOVE

blog article

Jul 24, 2018

Measles is a highly contagious disease that used to be common in young children. Due to the development of vaccines, however, it’s been almost eradicated. Almost, because there are several communities in the United States that still experience a high rate of measles infections. Mostly the outb...

Read More

Finding drugs that are safe to take while pregnant FINDING DRUGS THAT ARE SAFE TO TAKE WHILE PREGNANT

blog article

Jul 23, 2018

Expectant mothers often face a dilemma about whether to take medication when they fall ill due to fears it might harm their unborn baby, but new research is unraveling which drugs are safe to take during pregnancy. Pregnant women are excluded from trials of new medications for ethical reasons, which...

Read More

Gestational Diabetes Increases Heart Disease Risk in Babies GESTATIONAL DIABETES INCREASES HEART DISEASE RISK IN BABIES

blog article

Jul 22, 2018

Gestational diabetes occurs in pregnant women who have high blood glucose (sugar) levels and have not previously had diabetes, usually around the 24th week. A 2014 study from the Center for Disease Control stated that gestational diabetes prevalence is as high as 9.2%. Gestational diabetes can affec...

Read More

X-ray Images to Get Colors X-RAY IMAGES TO GET COLORS

blog article

Jul 20, 2018

In the near future, the X-ray images from your doctor's office will no longer be just black and white, at least that's what MARS Bioimaging Ltd, an imaging company based in New Zealand, hopes. Why are they so confident? A CERN (yes the organization that built the Large Hadron Collider)-devel...

Read More

FDA Opens Door to Importing Scarce and Costly Drugs FDA OPENS DOOR TO IMPORTING SCARCE AND COSTLY DRUGS

blog article

Jul 20, 2018

For years, consumer advocates and state officials have pushed for access to less expensive prescription medicines available overseas, only to meet stiff resistance from FDA and government health authorities claiming that such action could bring unsafe and harmful products into the U.S. This oppositi...

Read More

Treating Dementia With The Healing Waves Of Sound TREATING DEMENTIA WITH THE HEALING WAVES OF SOUND

blog article

Jul 20, 2018

Ultrasound waves applied to the whole brain improve cognitive dysfunction in mice with conditions simulating vascular dementia and Alzheimer’s disease. The research, conducted by scientists at Tohoku University in Japan, suggests that this type of therapy may also benefit humans.

Read More

Stopping Structural Changes in Collagen may Prevent Lung Fibrosis STOPPING STRUCTURAL CHANGES IN COLLAGEN MAY PREVENT LUNG FIBROSIS

blog article

Jul 19, 2018

Lung fibrosis is a serious condition that thickens tissues in the lungs and makes it hard to breathe. It can be caused by a variety of environmental factors, including exposure to coal or grain dust. New work has shown that it may be possible to prevent the disease with a drug that can block structu...

Read More

Immunotherapy Increases Survival of Melanoma Brain Metastases Patients IMMUNOTHERAPY INCREASES SURVIVAL OF MELANOMA BRAIN METASTASES PATIENTS

blog article

Jul 18, 2018

Melanoma, a form of skin cancer, accounts for about 1% of all skin cancer cases and a vast majority of skin cancer deaths. In Stage IV melanoma more than 60% of patients will develop brain metastases, which is difficult to treat and carries an overall survival of about 4-5 months. A recent study out...

Read More

Fighting A Common Viral Infection In Kidney Transplant Patients FIGHTING A COMMON VIRAL INFECTION IN KIDNEY TRANSPLANT PATIENTS

blog article

Jul 18, 2018

Organ transplants save lives, but the immune-suppressing drugs needed to protect a transplant leave the recipient susceptible to potentially deadly infections like cytomegalovirus, or CMV. Now, a team of researchers is trying to predict which kidney transplant patients might be at risk. With the hel...

Read More

CT Scans May Increase The Risk Of Brain Cancer CT SCANS MAY INCREASE THE RISK OF BRAIN CANCER

blog article

Jul 18, 2018

A new study in the Journal of the National Cancer Institute suggests that CT scans, commonly used in medical imaging, may increase the risk of brain tumors. The use of computed tomography (CT) scans has increased dramatically over the last two decades. CT scans greatly improve diagnostic capabilitie...

Read More

Artificial Intelligence for Diagnosing and Typing Tumors ARTIFICIAL INTELLIGENCE FOR DIAGNOSING AND TYPING TUMORS

blog article

Jul 18, 2018

While most think of artificial intelligence (AI) as the stuff of sci-fi movies and futuristic novels, it actually has many medical applications. From brain-computer interfaces for patients who have been paralyzed by injury or disease to machine learning for prosthetic limbs, AI is a game changer in ...

Read More

Powering up the Elderly POWERING UP THE ELDERLY'S IMMUNE SYSTEM

blog article

Jul 17, 2018

As we age our immune system weakens, leading to diseases such as influenza and pneumonia taking a toll on the elderly across the world. For people over 65 years of age infections are a leading cause of death, with an estimated 85% of all deaths from pneumonia in 2013 in the United States occurring i...

Read More

Heart Failure Death Rates Higher in Females than Males HEART FAILURE DEATH RATES HIGHER IN FEMALES THAN MALES

blog article

Jul 17, 2018

Heart failure is a common cause of morbidity and mortality, despite progress made over the past 10 years, more than 6 million Americans live with heart failure, and over 900,000 new cases are diagnosed each year. There are known sex-based differences in risk factors, presentation, and management of ...

Read More

Can the Keto Diet Make Cancer Treatment More Effective? CAN THE KETO DIET MAKE CANCER TREATMENT MORE EFFECTIVE?

blog article

Jul 17, 2018

It’s been said that “you are what you eat” but with so many diet plans and trends, it can be hard to choose. Paleo, keto, Mediterranean, and Nordic are all ways of eating that emphasize “clean eating” in different ways. Are they just trends or can they produce real...

Read More

Solving pharma’s patient services paradox SOLVING PHARMA’S PATIENT SERVICES PARADOX

blog article

Jul 16, 2018

Pharma companies are expending considerable time, energy and money on developing services that are designed to support patients before, during and after treatment across therapeutic areas. But there’s a paradox at the heart of these patient services. Although patients want them and pharma comp...

Read More

Omega-3-derived cannabinoid may stop cancer OMEGA-3-DERIVED CANNABINOID MAY STOP CANCER

blog article

Jul 16, 2018

Our bodies have an "endogenous," or "built-in," pain-killing system named after the cannabis plant: the endogenous cannabinoid system, otherwise known as the endocannabinoid system. Endocannabinoids are molecules that, together with their receptors, can be found throughout the bo...

Read More

New Drug Target For Remyelination In Multiple Sclerosis NEW DRUG TARGET FOR REMYELINATION IN MULTIPLE SCLEROSIS

blog article

Jul 16, 2018

Remyelination, the spontaneous regeneration of the fatty insulator in the brain that keeps neurons communicating, has long been seen as crucial to the next big advance in treating multiple sclerosis (MS). However, a lack of understanding of how remyelination is stymied in the disease has hampered th...

Read More

6 REASONS FOR DELAYED TREATMENT OF LYME DISEASE 6 REASONS FOR DELAYED TREATMENT OF LYME DISEASE

blog article

Jul 16, 2018

The key to killing Lyme disease bacteria successfully depends, in part, upon identifying the disease early on. Unfortunately, in all too many cases, individuals harboring the infection are not diagnosed early, which can lead to a delay in treatment and an increased risk of long-term complications.&n...

Read More

Brain Disease and High Blood Pressure BRAIN DISEASE AND HIGH BLOOD PRESSURE

blog article

Jul 15, 2018

Research recently published in the medical journal, Neurology, found a link between high blood pressure and brain disease. As many as half of American adults have high blood pressure and do not even know it. High blood pressure, or hypertension, occurs when the force of blood flow through your blood...

Read More

Nature Is Proving To Be Awesome Medicine For PTSD NATURE IS PROVING TO BE AWESOME MEDICINE FOR PTSD

blog article

Jul 13, 2018

The awe we feel in nature can dramatically reduce symptoms of post-traumatic stress disorder, according to UC Berkeley research that tracked psychological and physiological changes in war veterans and at-risk inner-city youth during white-water rafting trips. Psychologists tested nature’s heal...

Read More

Scientists from UofA are changing the face of viral pathogen treatment SCIENTISTS FROM UOFA ARE CHANGING THE FACE OF VIRAL PATHOGEN TREATMENT

blog article

Jul 12, 2018

The University of Alberta appears to have hit the nail on the head yet again. With so much inspiring research coming out of this campus, it should come as no surprise that they have made a significant discovery that has the potential to treat viral pathogens such as the Zika virus and respiratory sy...

Read More

Brain tumour chemotherapy now available to even more NHS patients BRAIN TUMOUR CHEMOTHERAPY NOW AVAILABLE TO EVEN MORE NHS PATIENTS

blog article

Jul 12, 2018

Science can be a painstakingly slow process. It can take years of tweaking, refining and rethinking to get solid, reliable evidence. And when it comes to developing new cancer treatments, the layers of research needed to go even deeper. Not only do scientists need to prove that a potential drug does...

Read More

Exploiting the brain tumor environment to make better treatments EXPLOITING THE BRAIN TUMOR ENVIRONMENT TO MAKE BETTER TREATMENTS

blog article

Jul 12, 2018

Scientists are used to exploring unfamiliar territories. It’s thanks to centuries of these investigations that we understand most of the human body enough to fix things when they go wrong. Unfortunately, some parts of the body remain somewhat of a mystery. And the brain is perhaps one of the g...

Read More

Solved protein puzzle opens door to new design for cancer drugs SOLVED PROTEIN PUZZLE OPENS DOOR TO NEW DESIGN FOR CANCER DRUGS

blog article

Jul 12, 2018

Researchers at Oregon State University have solved a longstanding puzzle concerning the design of molecular motors, paving the way toward new cancer therapies. Findings were published today in Current Biology. The research involved kinesins: tiny, protein-based motors that interact with microtubules...

Read More

Innovative Development of Product Portfolio to Stimulate Production Sales of Vital Signs Monitoring Device INNOVATIVE DEVELOPMENT OF PRODUCT PORTFOLIO TO STIMULATE PRODUCTION SALES OF VITAL SIGNS MONITORING DEVICE

blog article

Jul 12, 2018

Low production cost has been significantly influencing the growth of the market for vital signs monitoring device across the globe. Apart from this, the major companies, as well as manufacturers, are working towards expanding the presence of their products with the help of several marketing activiti...

Read More

Parkinson’s Foundation Prevalence Project Finds Number of People With Parkinson’s Severely Underestimated PARKINSON’S FOUNDATION PREVALENCE PROJECT FINDS NUMBER OF PEOPLE WITH PARKINSON’S SEVERELY UNDERESTIMATED

blog article

Jul 10, 2018

When a large population of people has a disease, like Parkinson’s disease (PD), it’s essential to have accurate numbers of how many people have the disease, where they live and why they have it. In our latest research initiative, we established the Parkinson’s Prevalence Project to...

Read More

Pharmaceutical Industry to Stimulate Production Sales of Peptide Therapeutics PHARMACEUTICAL INDUSTRY TO STIMULATE PRODUCTION SALES OF PEPTIDE THERAPEUTICS

blog article

Jul 10, 2018

The rapid increase in FDI and rising healthcare expenditure has been driving the adoption of peptide therapeutics across the globe. Apart from this, growing prevalence of metabolic and cardiovascular disorders has been leading to a rapid increase in R&D activities with regards to usage of peptid...

Read More

Cancer treatments should depend on the type of tumor CANCER TREATMENTS SHOULD DEPEND ON THE TYPE OF TUMOR

blog article

Jul 10, 2018

Traditionally, cancers have been treated according to the part of the body they are diagnosed in, like the breast, lungs, or bowel. But a new study from California’s Buck Institute for Research on Aging analyzed 33 cancer types and reclassified them into 28 molecular types, or ‘clus...

Read More

Graphene in the fight against antimicrobial resistant bacteria GRAPHENE IN THE FIGHT AGAINST ANTIMICROBIAL RESISTANT BACTERIA

blog article

Jul 10, 2018

The overuse of antibiotics has led to antimicrobial resistant bacteria that threaten the lives of hundreds of millions. In the search for alternative ways to fight bacteria, a recent study published in Burns & Trauma turns to a composite of the world’s strongest known material, graphene, a...

Read More

Engineering a Better Heart Valve ENGINEERING A BETTER HEART VALVE

blog article

Jul 09, 2018

Over 5 million Americans have heart valve disease (HVD), which can lead to heart failure, stroke, blood clots, and even death. HVD occurs when one or more of the four valves of the heart does not work properly, disrupting the flow of blood through your heart. The human heart has four valves: ao...

Read More

Bioelectronic Medicine: Technology Targeting Molecular Mechanisms BIOELECTRONIC MEDICINE: TECHNOLOGY TARGETING MOLECULAR MECHANISMS

blog article

Jul 09, 2018

In this blog, Margot Puerta reports on the Bioelectronic Medicine: Technology Targeting Molecular Mechanisms symposium which took place in June. This three-day meeting had the aim of developing the field of bioelectronic medicine and brought together leading scientists and industry leaders from arou...

Read More

Branded Drug Products to Significantly Stimulate Production Sales of Pharmaceuticals BRANDED DRUG PRODUCTS TO SIGNIFICANTLY STIMULATE PRODUCTION SALES OF PHARMACEUTICALS

blog article

Jul 06, 2018

The rapid increase in the cases related to non-communicable diseases and growing penetration of the health insurance companies, resulting in low treatment costs, thereby influencing healthcare providers for prescribing generic drugs have been contributing towards the substantial growth of Saudi Arab...

Read More

Supporting the Development of Regenerative Medicines SUPPORTING THE DEVELOPMENT OF REGENERATIVE MEDICINES

blog article

Jul 06, 2018

Regenerative medicine can be defined as a branch of translational research which focuses on methods to regrow, repair or replace human cells, tissues or organs. This approach holds promise for revolutionary new cures for devastating conditions such as heart disease, diabetes, and cancer. We recently...

Read More

Researchers Investigate Drug to Help Veterans With PTSD Sleep Better At Night RESEARCHERS INVESTIGATE DRUG TO HELP VETERANS WITH PTSD SLEEP BETTER AT NIGHT

blog article

Jul 06, 2018

A study into whether or not a new investigational drug could help veterans cope with trauma-related sleep disturbances is in its final phase of clinical research. Started this past January by Tonix Pharmaceuticals, the HONOR study is investigating the effectiveness of new medication intended to...

Read More

BMC Medicine at Digestive Disease Week 2018 BMC MEDICINE AT DIGESTIVE DISEASE WEEK 2018

blog article

Jul 06, 2018

BMC Medicine joined Digestive Disease Week in 2018, the largest GI conference worldwide, held last June in Washington DC. Here we look at some of the highlights from the meeting. Attendance to the Digestive Disease Week 2018 gathering was marked by the impressive presence of around 32,000 parti...

Read More

Digital Therapeutics: How to Ensure Quality in an Emerging Field DIGITAL THERAPEUTICS: HOW TO ENSURE QUALITY IN AN EMERGING FIELD

blog article

Jul 05, 2018

Imagine using the software on your phone or tablet to treat health conditions that, until now, could only be treated with medications. Now stop imagining, because, for some conditions, such as attention deficit disorder and substance dependency, it is already a reality. I’m talking about the n...

Read More

Discovery of New Properties of an Anti-Tuberculosis Drug DISCOVERY OF NEW PROPERTIES OF AN ANTI-TUBERCULOSIS DRUG

blog article

Jul 04, 2018

Investigators at the University of Otago found novel properties of a new anti-tuberculosis drug which may inspire more new drugs to treat tuberculosis. Tuberculosis (TB), as well as TB resistant drugs, are responsible for about 1.7 million global deaths per year. In a collaboration, Greg Cook a prof...

Read More

Increased Dose of Drug INCREASED DOSE OF DRUG 'RIFAMPIN' EFFECTIVE IN ELIMINATING TUBERCULOSIS BACTERIUM

blog article

Jul 04, 2018

According to a randomized controlled trial, a TB drug by the name ‘Rifampin’ was seen to effectively kill TB bacteria in sputum cultures when administered at an increased dose per day. In the publication "Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomi...

Read More

Four steps to building an innovation culture in pharma FOUR STEPS TO BUILDING AN INNOVATION CULTURE IN PHARMA

blog article

Jul 04, 2018

The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the blockbuster drugs birthed in the 1990s, such as Lipitor and Humira, pharma has always been on a quest for novel, groundbreaking drug developm...

Read More

5 Golden Rules For Effective (And Inspection Ready) OOS Investigations 5 GOLDEN RULES FOR EFFECTIVE (AND INSPECTION READY) OOS INVESTIGATIONS

blog article

Jul 04, 2018

The investigation of out of specification (OOS) results is a regulatory requirement in a GMP laboratory, and these investigations are intensively scrutinized by health authority inspectors. The purpose of this article is to provide five Golden Rules that will ensure investigations are both effective...

Read More

Researcher uses HPV vaccine to treat patients with skin cancer RESEARCHER USES HPV VACCINE TO TREAT PATIENTS WITH SKIN CANCER

blog article

Jul 03, 2018

Squamous cell carcinoma is the second-most-common form of skin cancer. Evidence suggests the human papilloma virus plays a role in the development of some types of this skin cancer. Two years ago, a 97-year-old woman whose right leg was covered with squamous cell tumors went to see dermatologist Ann...

Read More

Malaria eradication: tackling counterfeit and substandard drugs MALARIA ERADICATION: TACKLING COUNTERFEIT AND SUBSTANDARD DRUGS

blog article

Jul 02, 2018

Although malaria is beginning to be eradicated, it remains a global health issue and this is partially due to the existence of counterfeit and substandard drugs in the regions where malaria remains most prevalent: South East Asia and Africa. What is the extent of the problem in these areas, and what...

Read More

New Regulations And Safety Complicate Drug Labeling NEW REGULATIONS AND SAFETY COMPLICATE DRUG LABELING

blog article

Jul 02, 2018

Multinational pharmaceutical companies have for decades manufactured drugs for global distribution. Nevertheless, the task of labeling is becoming increasingly difficult and time-consuming. With new labeling requirements that can vary by country and region, drug companies are forced to either develo...

Read More

Adamis Pharma Sells Epinephrine Injector Rights to Novartis ADAMIS PHARMA SELLS EPINEPHRINE INJECTOR RIGHTS TO NOVARTIS

blog article

Jul 02, 2018

Adamis Pharmaceuticals is selling U.S. commercial rights to Symjepi, a competitor to Mylan’s EpiPen, to Novartis.Although financial details were not released, Novartis’ Sandoz division will pay Adamis an upfront fee and various performance-based milestone payments. Net profits in the U.S...

Read More

Use of State Medicaid Inflation Rebates Could Discourage Drug Price Increases USE OF STATE MEDICAID INFLATION REBATES COULD DISCOURAGE DRUG PRICE INCREASES

blog article

Jun 28, 2018

List prices for prescription drugs set by the manufacturer before discounts and rebates have grown faster  than the rate of inflation.1  In 2015, average drug list prices increased by 6.4 percent, while general inflation only increased by 0.1 percent. 2 Although price concessions, primaril...

Read More

How to achieve digital success in pharma’s communications HOW TO ACHIEVE DIGITAL SUCCESS IN PHARMA’S COMMUNICATIONS

blog article

Jun 27, 2018

Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game-changing factors for pharma communications according to Katrine Bach, the CEO of Anthill Agency. Bach, spoke to pharmaphorum for the Future Pharma issue of its Deep Dive digital ma...

Read More

Sino-American Pharma Pros draws China, U.S. drugmakers to Philly SINO-AMERICAN PHARMA PROS DRAWS CHINA, U.S. DRUGMAKERS TO PHILLY

blog article

Jun 25, 2018

In a cheerful cacophony of start-up and recruiter pitches, emerging-science talks and investment-banking tips, laptop displays and card exchanges  in English and in Mandarin more than 1,000 Philadelphia-area scientists, pharma professionals, and people who want to do business with them  ja...

Read More

Pharma Companies Secure About $250 Million in Financing Today PHARMA COMPANIES SECURE ABOUT $250 MILLION IN FINANCING TODAY

blog article

Jun 19, 2018

Venture capitalists are flexing their muscles today with the significant support of pharma and biotech companies. Approximately $250 million in financing has been secured to support various pipelines to address multiple concerns. Boston-based Decibel Therapeutics secured $55 million in a Series C fi...

Read More

New Study Shows Drug War Sends Users to Dark Web NEW STUDY SHOWS DRUG WAR SENDS USERS TO DARK WEB

blog article

Jun 19, 2018

A new study published in the British journal BMJ says restricting the supply of illegal drugs forces users into black markets, where the drugs get more dangerous and more addictive. The authors of the study looked at the effect of the DEA's rescheduling of hydrocodone in 2014 from a schedule III...

Read More

Global Halal Pharmaceuticals Market will reach 540 million US$ in 2023 with Double Digit CAGR GLOBAL HALAL PHARMACEUTICALS MARKET WILL REACH 540 MILLION US$ IN 2023 WITH DOUBLE DIGIT CAGR

blog article

Jun 18, 2018

A new market study, titled “Global Halal Pharmaceuticals Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023”, has been featured on WiseGuyReports.Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmace...

Read More

Active Pharmaceutical Ingredients (API): Global Markets Estimated to Reach 154.7 billion by 2022 ACTIVE PHARMACEUTICAL INGREDIENTS (API): GLOBAL MARKETS ESTIMATED TO REACH 154.7 BILLION BY 2022

blog article

Jun 18, 2018

This report (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing trends and regulatory guidelines ...

Read More

How Correctional Facilities Could Lower Drug Prices HOW CORRECTIONAL FACILITIES COULD LOWER DRUG PRICES

blog article

Jun 14, 2018

State and local correctional facilities, including prisons and jails, are required to provide health care to incarcerated adults.1 Drug spending has an outsize impact on correctional health care budgets: Of the states that report drug spending, the majority spend more than 15 percent of their health...

Read More

North Carolina Bill Would Make Prescription Records Available to Police Without a Warrant NORTH CAROLINA BILL WOULD MAKE PRESCRIPTION RECORDS AVAILABLE TO POLICE WITHOUT A WARRANT

blog article

Jun 12, 2018

America’s opioid epidemic is a grave public health issue, one that experts and a growing national consensus say we need to approach with solutions based in science and treatment. Unfortunately, some lawmakers haven’t gotten the memo and want to continue with the failed and inhumane strat...

Read More

Psychedelic drugs could inspire new medications to treat depression and anxiety PSYCHEDELIC DRUGS COULD INSPIRE NEW MEDICATIONS TO TREAT DEPRESSION AND ANXIETY

blog article

Jun 12, 2018

Drugs like LSD help neurons reach out to each other, a promising path for pharmaceutical development. In a new study, researchers looked at a range of psychedelic drugs and their effects on neurons in the petri dish and tested one drug in rats. They found that these drugs help neurons branch out and...

Read More

How pharma hides data about farm antibiotic use HOW PHARMA HIDES DATA ABOUT FARM ANTIBIOTIC USE

blog article

Jun 11, 2018

ON Wednesday  last week, the non-profit Natural Resources Defense  Council revealed that pig herds in the United States receive almost as many antibiotics as people in this country do. That’s bad news, especially since most of the pigs receiving antibiotics aren’t sick, but ins...

Read More

Aspirin for prevention: A look at the potential benefits and risks ASPIRIN FOR PREVENTION: A LOOK AT THE POTENTIAL BENEFITS AND RISKS

blog article

Jun 07, 2018

When my doctor first asked me to take aspirin, I wasn’t so sure I needed it. Since the 1980s, aspirin has a proven record of preventing second heart attacks and strokes, but its use in people without these problems was and remains a source of confusion for both doctors and patients. Why take a...

Read More

Nigeria’s drug makers upgrade factories to push for more WHO certifications NIGERIA’S DRUG MAKERS UPGRADE FACTORIES TO PUSH FOR MORE WHO CERTIFICATIONS

blog article

Jun 05, 2018

The quest to obtain the World Health Organisation (WHO)’s prequalification is pushing more local pharmaceutical companies into upgrading their machinery and factories, with a number of them investing in new facilities. The WHO prequalification enables a pharmaceutical company to participate in...

Read More

Study finds rare gain for tough-to-treat pancreatic cancer STUDY FINDS RARE GAIN FOR TOUGH-TO-TREAT PANCREATIC CANCER

blog article

Jun 04, 2018

Patients with pancreatic cancer that hadn’t spread lived substantially longer on a four-drug combo than on a single standard cancer drug, a rare advance for a tough-to-treat disease, researchers reported Monday. The results indicate the powerful chemotherapy treatment known as folfirinox will ...

Read More

Blockchain to Shape Next Generation Healthcare Supply Chains BLOCKCHAIN TO SHAPE NEXT GENERATION HEALTHCARE SUPPLY CHAINS

blog article

Jun 01, 2018

Blockchain technology will play a key role in supporting supply chain transformation in the healthcare sector by helping to reduce fraud and better manage quality in the manufacturing and distribution of pharmaceutical products, according to leading data and analytics company GlobalData.Counterfeiti...

Read More

Three charged over dangerous drugs, Arundel THREE CHARGED OVER DANGEROUS DRUGS, ARUNDEL

blog article

Jun 01, 2018

Police have charged three people following the alleged discovery of dangerous drugs at Arundel this morning.It is alleged that around 7.20am, officers from the Rapid Action Patrol group executed a search warrant at a private residence on Portreeves Place, where they allegedly located methamphetamine...

Read More

Madrigal pharma more than doubles after liver drug study success MADRIGAL PHARMA MORE THAN DOUBLES AFTER LIVER DRUG STUDY SUCCESS

blog article

May 31, 2018

Madrigal Pharmaceuticals Inc’s shares more than doubled after mid-stage trial data showed its lead drug reduced liver fat in patients with fatty liver disease, placing it ahead of larger rivals to tap into a potential market worth $30 billion.Often dubbed the “silent disease” becau...

Read More

Native American Tribes, State and Local Governments Sue Pharmaceutical Companies Over Opioid Abuse Crisis NATIVE AMERICAN TRIBES, STATE AND LOCAL GOVERNMENTS SUE PHARMACEUTICAL COMPANIES OVER OPIOID ABUSE CRISIS

blog article

May 30, 2018

In a desperate attempt to fill their empty coffers and convince voters they are doing something -- anything -- to stop the current opioid abuse epidemic, hundreds of cities, counties, Native American tribes and hospitals are suing pharmaceutical companies for their role in the opioid abuse crisis.&n...

Read More

Decoding the deadly Nipah virus DECODING THE DEADLY NIPAH VIRUS

blog article

May 28, 2018

A virus named after Kampung Sungai Nipah, a village in Malaysia, where it was first discovered in 1998-99. The virus, that eventually killed 105 people in Malaysia, was first suspected to be Japanese encephalitis (JE) which, like the Nipah virus, induces brain inflammation. According to a paper by D...

Read More

Oncology drives major pharma deals while immuno-oncology patent activity soars ONCOLOGY DRIVES MAJOR PHARMA DEALS WHILE IMMUNO-ONCOLOGY PATENT ACTIVITY SOARS

blog article

May 23, 2018

Cancer immunotherapy is an exciting, relatively new therapy that treats cancer by unleashing the power of the immune system. It has been hailed as one of the most promising advances in the treatment of cancer in recent times. Immuno-oncology research is growing at a rapid pace and for the last three...

Read More

How Big Pharma forces us to buy drugs instead of cannabis HOW BIG PHARMA FORCES US TO BUY DRUGS INSTEAD OF CANNABIS

blog article

May 23, 2018

Simply put, Big Pharma has been a long time opponent of legalizing medical marijuana as it threatens to ruin its business and drop the market cap for pharmaceutical drug companies.Even though medical cannabis has been legalized in more than half of the US states, all of Canada and in Mexico, prices ...

Read More

Doctors who got free lunches from Big Pharma were more likely to prescribe opioids DOCTORS WHO GOT FREE LUNCHES FROM BIG PHARMA WERE MORE LIKELY TO PRESCRIBE OPIOIDS

blog article

May 22, 2018

Is a life worth a free meal? This might not exactly be the way the question is phrased in a research letter published in JAMA, yet that’s the underlying assumption you’re left with. After reviewing two years of data on prescription rates, it appears doctors were influenced by free meals ...

Read More

Vermont Drug Importation Program Is Not Illegal VERMONT DRUG IMPORTATION PROGRAM IS NOT ILLEGAL

blog article

May 18, 2018

In its wisdom and activist spirit, Vermont has a new law on the books allowing for the wholesale importation of FDA-approved drugs from authorized wholesalers in Canada. Canadian wholesale pharmacies sell many brand-name drugs at much lower costs than their U.S. counterparts. This could help patient...

Read More

Big Pharma Bribes Linked To Doctors Prescribing Large Quantities Of Opioids BIG PHARMA BRIBES LINKED TO DOCTORS PRESCRIBING LARGE QUANTITIES OF OPIOIDS

blog article

May 15, 2018

(DCNF) Major pharmaceutical companies heavily influenced doctors to prescribe high rates of opioid medications with lavish spending, new research suggests. Doctors, who received paid speaking gigs, free lunches and branded merchandise from drug makers, were linked to much high rates of opioid prescr...

Read More

Can Hot Dogs Influence the Drugs a Doctor Prescribes? CAN HOT DOGS INFLUENCE THE DRUGS A DOCTOR PRESCRIBES?

blog article

May 15, 2018

A stroll around the exhibit area of the American Psychiatric Association Conference demonstrates how pharma marketing can influence the prescribing patterns of doctors — possibly at the expense of patients' health. If you were walking around the exhibit halls of the Jacob K. Javits Convent...

Read More

Trump Drug Pricing Plan Outlines Rule Changes Pharma Can Live With TRUMP DRUG PRICING PLAN OUTLINES RULE CHANGES PHARMA CAN LIVE WITH

blog article

May 14, 2018

After months of expectations and repeated delays, President Donald Trump formally announced his strategy for making prescription medicines more affordable and accessible in the U.S. Trump promised to take on the “tangled web of special interests” that drive up drug prices, noting the hig...

Read More

Jeff Sessions decision to re-up in the drug war won JEFF SESSIONS DECISION TO RE-UP IN THE DRUG WAR WON'T WORK

blog article

May 14, 2018

Attorney General Jeff Sessions’ newly issued sentencing directive to federal prosecutors, revoking the Obama-era Smart on Crime Initiative, is a devastating revival of the War on Drugs. The repercussions of this move will undoubtedly reverse the decline in the federal prison population of rece...

Read More

Big Pharma funds opioid training. What could go wrong? BIG PHARMA FUNDS OPIOID TRAINING. WHAT COULD GO WRONG?

blog article

May 12, 2018

The ‘Global and Chinese Nasal Drug Delivery Technology Industry, 2013-2023 Market Research Report’ is a professional and in-depth study on the current state of the global Nasal Drug Delivery Technology industry with a focus on the Chinese market. The report provides key statistics on the...

Read More

Trump Speaks About Proposal to Lower U.S. Drug Prices TRUMP SPEAKS ABOUT PROPOSAL TO LOWER U.S. DRUG PRICES

blog article

May 11, 2018

President Donald Trump is expected to unveil a proposal today to bring down U.S. drug prices. The blueprint, called American Patients First, is meant to increase pharmaceutical competition and lower patients’ out-of-pocket costs. Trump is scheduled to speak about the plan's details at 2 p....

Read More

President set to outline drug pricing plan: how far will it go? PRESIDENT SET TO OUTLINE DRUG PRICING PLAN: HOW FAR WILL IT GO?

blog article

May 10, 2018

Tomorrow at 2 p.m., EST,  the President is scheduled to deliver a long-awaited drug pricing strategy speech to put “America’s patients first.”  While details of the speech have been closely held, it is anticipated that it will  discuss a “comprehensive strategy...

Read More

Local pharmaceuticals innovate new drugs amid codeine crisis LOCAL PHARMACEUTICALS INNOVATE NEW DRUGS AMID CODEINE CRISIS

blog article

May 10, 2018

It was an irony of sorts that while the National Agency for Food and Drug Administration and Control (NAFDAC) was announcing a ban on three pharmaceutical firms over codeine-containing syrup on Tuesday, an Anambra State-based drug maker, Juhel Nigeria, was getting set to unveil its new Oxytocin inje...

Read More

FG codeine ban, Emzor Pharma closure a knee jerk response – Experts FG CODEINE BAN, EMZOR PHARMA CLOSURE A KNEE JERK RESPONSE – EXPERTS

blog article

May 09, 2018

The recent ban on codeine-containing cough syrup by the Federal Government, shutting down Emzor Pharmaceuticals Ind. Ltd., Peace Standard Pharmaceutical Limited and Bioraj Pharmaceutical Limited is a knee jerk response to the drug abuse problem experts have said. The ban is echoing in the public spa...

Read More

Contraceptive Pills Market 2018 Size and Growth Factors Research with Topmost Leading Vendors CONTRACEPTIVE PILLS MARKET 2018 SIZE AND GROWTH FACTORS RESEARCH WITH TOPMOST LEADING VENDORS

blog article

May 09, 2018

Anti-conception medication pills which are also called as oral contraceptive pills are a kind of female hormonal anti-conception medication technique and are extremely viable at avoiding pregnancy. The Pills are small tablets that a patient swallow every day. Most pills contain two sorts of manufact...

Read More

Weak Sector Earnings Dragging Pharmaceutical ETFs Down WEAK SECTOR EARNINGS DRAGGING PHARMACEUTICAL ETFS DOWN

blog article

May 07, 2018

From Zacks: Total earnings for 83.1% of the total healthcare market capitalization are up 14.7% on revenue growth of 8.1%. The growth rates seem unimpressive when compared with some of the other sectors. Earnings and revenue beat ratios of 88.9% and 75%, respectively, are also not great either. Amon...

Read More

Drug Take Back Day Sets State Record DRUG TAKE BACK DAY SETS STATE RECORD

blog article

May 04, 2018

The Manchester Police Department collected 33 pounds of medication for disposal at the Drug Take Back Day Saturday at Brehme Drug.  Residents of the state disposed of 12,333 pounds of old or unused prescription drugs during Saturday’s event. According to the Governor’s Office of Dru...

Read More

How synthetic opioids can radically change global illegal drug markets and foreign policy HOW SYNTHETIC OPIOIDS CAN RADICALLY CHANGE GLOBAL ILLEGAL DRUG MARKETS AND FOREIGN POLICY

blog article

Apr 30, 2018

Replacing drugs derived from plants (e.g., heroin, cannabis) with synthetic analogues (e.g., fentanyl, spice/K2) could be the most disruptive innovation in the history of the international drug trade. As we explain in the current issue of Foreign Affairs, it may also alter international relations an...

Read More

blolg - pharma test BLOLG - PHARMA TEST

blog article

Apr 30, 2018

This article is part of a series on Corporate law Society.svg By jurisdiction[show] General corporate forms[show] Corporate forms by jurisdiction[show] Doctrines[show] Related areas[show] Company portal Law portal v t e A company, abbreviated as co., is a legal entity made up of an association of pe...

Read More

International Drug Price Comparisons for Medicare Part D Medications INTERNATIONAL DRUG PRICE COMPARISONS FOR MEDICARE PART D MEDICATIONS

blog article

Apr 26, 2018

Senator Claire McCaskill (D-MO) requested an investigation into drug price increases among the Medicare Part D program’s 20 most widely-prescribed medications over a five-year period. The investigation, conducted by the Senate Committee on Homeland Security and Government Affairs, found that a...

Read More

Orexigen opens bidding process, selling itself for $75 million OREXIGEN OPENS BIDDING PROCESS, SELLING ITSELF FOR $75 MILLION

blog article

Apr 25, 2018

To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription.  Please login or subscribe in ...

Read More

Pharmaceuticals Grade Sodium Bicarbonate Market: North America to Remain at Leading Position through 2027 PHARMACEUTICALS GRADE SODIUM BICARBONATE MARKET: NORTH AMERICA TO REMAIN AT LEADING POSITION THROUGH 2027

blog article

Apr 23, 2018

Sodium bicarbonate is usually utilized as an active pharmaceutical excipient and component, in pharmaceutical industry. It is fundamentally employed for the treatment of cardiac arrest, circulatory insufficiency, and hemodialysis. Future Market Insights has published a report on global pharmaceutica...

Read More

How to talk to your doctor about medication HOW TO TALK TO YOUR DOCTOR ABOUT MEDICATION

blog article

Apr 23, 2018

Pharmacology has changed the practice of medicine. Scientists are continually working on new and better drugs to manage medical conditions, from high blood pressure to autoimmune diseases to cancer. The mechanism of a drug how it actually works on the condition it is mean to treat is one important f...

Read More

Regulating Self-Driving Cars Like Pharmaceuticals Is a Really Stupid Idea REGULATING SELF-DRIVING CARS LIKE PHARMACEUTICALS IS A REALLY STUPID IDEA

blog article

Apr 18, 2018

After Elaine Herzberg became the first person killed by a self-driving car, the proponents of government control quickly urged greater federal regulation of the nascent industry. But such regulation would not enhance safety. Most likely, it would kill more people, by delaying the deployment of safer...

Read More

Patient-centric networks at the heart of pharmaceutical supply chain management: Lessons from LogiPharma Europe 2018 PATIENT-CENTRIC NETWORKS AT THE HEART OF PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT: LESSONS FROM LOGIPHARMA EUROPE 2018

blog article

Apr 18, 2018

In early April I attended the LogiPharma Europe 2018 conference in Montreux, Switzerland, an event that attracted more than 800 attendees, including practitioners and executives from pharma and medical device industries, along with software vendors and many service providers. Here are some key takea...

Read More

Attorney General Sessions Proposes An Even More Destructive Opioid Policy ATTORNEY GENERAL SESSIONS PROPOSES AN EVEN MORE DESTRUCTIVE OPIOID POLICY

blog article

Apr 18, 2018

Speaking to a group of law enforcement officials in Raleigh, NC yesterday, Attorney General Jeff Sessions announced proposed rule changes to the way the Drug Enforcement Administration sets quotas on the manufacturing of opioids. The DEA now presumes to be able to divine the likelihood a particular ...

Read More

UK drug discovery startup BenevolentAI raises $115M UK DRUG DISCOVERY STARTUP BENEVOLENTAI RAISES $115M

blog article

Apr 18, 2018

U.K.-based artificial intelligence company BenevolentAI Ltd. today announced the completion of a $115 million funding round that values the London startup at a cool $2 billion. The round, said to be one of the largest ever in the AI pharmaceutical sector, was led by BevenolentAI’s existing bac...

Read More

Multi-material shipping container for pharmaceuticals MULTI-MATERIAL SHIPPING CONTAINER FOR PHARMACEUTICALS

blog article

Apr 17, 2018

Containerization, or massing smaller pieces of cargo together in a single, larger container, was first practiced for shipping of coal in 17th Century England. The idea has evolved since into the now-ubiquitous stackable intermodal containers seen on container ships, trains and trucks. Likewise, the ...

Read More

Alliance pharma sells chinese business for £2.9 million ALLIANCE PHARMA SELLS CHINESE BUSINESS FOR £2.9 MILLION

blog article

Apr 17, 2018

Wiltshire-based Alliance Pharma, the specialty pharmaceutical group, have announced that it has agreed to sell its 60% interest in non-core Unigreg Limited to its joint venture partner, Pacific Glory Development Limited, for £2.9 million. Unigreg owns the rights to Forceval, a micro-nutrient s...

Read More

Amazon vs. Walmart: Can Corporate America Lower Drug Prices? AMAZON VS. WALMART: CAN CORPORATE AMERICA LOWER DRUG PRICES?

blog article

Apr 10, 2018

The former statement comes as no surprise. Americans spend $450 billion on medications annually, a figure projected to reach as much as $610 billion by 2021.(www.cnbc.com) Every family physician knows patients who have cut their meds in half, skipped doses or simply forgone medications because they ...

Read More

Pharma firms could report weak numbers PHARMA FIRMS COULD REPORT WEAK NUMBERS

blog article

Apr 09, 2018

The troubled pharma sector is expected to report weak Q4FY18 numbers, with their profit after tax (PAT) likely to decline by 9 per cent year-on-year (YoY) and rupee appreciation may put pressure on their realisations, industry analysts said. Edelweiss research analyst Deepak Malik said the firm expe...

Read More

Rewriting Pharma’s Talent Blueprint REWRITING PHARMA’S TALENT BLUEPRINT

blog article

Apr 09, 2018

If you are searching for the best current example of the future career path of pharmaceutical executives, look no further than the April 2017 appointment of GlaxoSmithKline’s CEO Emma Walmsley. While she has been with GSK since 2010, Walmsley joined the pharma giant after 17 years with L&rsquo...

Read More

Trading Big Pharma for Small Startup TRADING BIG PHARMA FOR SMALL STARTUP

blog article

Apr 08, 2018

After speaking with at least a half-dozen C-suite level executives who made the leap from big pharma to lesser-known startup or biotech companies, it’s very clear that there is something deep down in their personalities that propelled them to make the move. Some of them were at the top of thei...

Read More

How Blockchain Can Improve the Pharma Manufacturing Supply Chain HOW BLOCKCHAIN CAN IMPROVE THE PHARMA MANUFACTURING SUPPLY CHAIN

blog article

Apr 06, 2018

The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines on the pharmacy shelves. It has been one of the top industry performers of the past three decades. By maintaining the highest safety and qual...

Read More

Rumored startup acquisition would boost Walmart RUMORED STARTUP ACQUISITION WOULD BOOST WALMART'S PHARMACEUTICAL PRESENCE

blog article

Apr 04, 2018

The retail giant is said to be in talks with online startup PillPack, which pre-sorts pills into date- and time-stamped packets for patients who take multiple drugs. Walmart Inc. is in early talks about a deal for closely held PillPack, an online startup that could help grow the retail giant’s...

Read More

Corvus Pharmaceuticals: A New Immunotherapy Player CORVUS PHARMACEUTICALS: A NEW IMMUNOTHERAPY PLAYER

blog article

Apr 04, 2018

The immune checkpoints are signaling molecules that act to shut down or block an immune response. In a healthy person, this mechanism is a "safety" feature allowing cessation of the immune response once it has performed its task. Cytotoxic T Lymphocyte Antigen 4 (CTLA‐4) and programmed Dea...

Read More

New York politician (and former Big Pharma member) wants to ban vaping and walking NEW YORK POLITICIAN (AND FORMER BIG PHARMA MEMBER) WANTS TO BAN VAPING AND WALKING

blog article

Apr 03, 2018

Just when you think you’ve heard everything, news comes out of New York that a certain democratic member of city council wants to make vaping and walking on sidewalks illegal.  The actual bill is currently geared towards making smoking illegal, but one can safely assume that vaping will a...

Read More

Add pharmaceuticals to the list of trade complaints ADD PHARMACEUTICALS TO THE LIST OF TRADE COMPLAINTS

blog article

Mar 28, 2018

International trade is in the news these days, almost on par with the media pumping the tale of porno star Stormy Daniels.  Even so, there's still an aspect of trade that gets far too little attention.  This is surprising, given that it adversely affects millions of Americans.  It...

Read More

Pharma Ocean Freight Enters New Waters PHARMA OCEAN FREIGHT ENTERS NEW WATERS

blog article

Mar 28, 2018

A new integrated ocean freight program for pharmaceuticals aims at a new approach to pharma-logistics fulfillment. The Posiedon project seeks to harness the collective knowledge of the supply chain to drive innovation, efficiencies, and safety and save money. “It’s the difference between...

Read More

Why Are Pharmaceutical Drugs So Expensive? Sen. McCaskill’s Report Misses Larger Picture WHY ARE PHARMACEUTICAL DRUGS SO EXPENSIVE? SEN. MCCASKILL’S REPORT MISSES LARGER PICTURE

blog article

Mar 28, 2018

On Monday, Senator Claire McCaskill’s office released a report examining overall price increases for the top 20 brand-name prescription drugs in the United States. According to the report, the price for these drugs increased an average of 12 percent every year for five years, more than 10 time...

Read More

Empty Capsules Market to Ride on Flourishing Pharmaceuticals Industry EMPTY CAPSULES MARKET TO RIDE ON FLOURISHING PHARMACEUTICALS INDUSTRY

blog article

Mar 27, 2018

A report recently added by Transparency Market Research to its repository, titled, “Empty Capsules Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016–2023,” delves deep into the market which forms a crucial part of the pharmaceutical industry wo...

Read More

How Can The Pharma Industry Help The Homeless? HOW CAN THE PHARMA INDUSTRY HELP THE HOMELESS?

blog article

Mar 23, 2018

In January I published, “Can JPM And BTS Make A Bigger Difference?” This was part one of a four-part blog series on my experience of attending this year’s J.P. Morgan Healthcare (JPM) and Biotech Showcase (BTS) conferences in San Francisco. In this particular blog, I wrote about th...

Read More

Getting to know the chief pharmaceutical officer GETTING TO KNOW THE CHIEF PHARMACEUTICAL OFFICER'S CLINICAL FELLOWS JUSTIN, TAHMINA AND KHOLA

blog article

Mar 22, 2018

I am currently based at Bupa and work alongside two fellows from the National Medical Director’s Clinical Fellow Scheme. Prior to the scheme I gained experience in various pharmacy specialities within secondary care. I am primarily a surgical specialist pharmacist although I have undertaken ro...

Read More

Bayer looks to leverage AI across the pharma value chain BAYER LOOKS TO LEVERAGE AI ACROSS THE PHARMA VALUE CHAIN

blog article

Mar 21, 2018

Bayer has already shown more than a passing interest in artificial intelligence through its digital accelerator programme Grants4Apps, but the company’s use of the technology looks to be more wide-ranging and deep-seated than that. Talking to journalists after the company’s Financial New...

Read More

Treatment for Post-Surgical Nausea and Vomiting TREATMENT FOR POST-SURGICAL NAUSEA AND VOMITING

blog article

Mar 20, 2018

Amisulpride, a drug developed for the treatment of schizophrenia, was studied to be effective in preventing postoperative nausea and vomiting (PONV). The drug was seen to decrease the development of PONV when used in combination with a standard anti-nausea treatment; administered intraoperatively.

Read More

The THE 'TRIPLE PILL': A NEW BLOOD PRESSURE TREATMENT

blog article

Mar 16, 2018

Even though there exists an abundance of blood pressure-lowering drugs, high blood pressure persists to be a health concern not only in the US but globally. Blood pressure can lead to heart attacks, kidney issues, as well as stroke; therefore, treating blood pressure is a crucial priority. On a glob...

Read More

The power of precision medicine in cancer drug discovery and treatment THE POWER OF PRECISION MEDICINE IN CANCER DRUG DISCOVERY AND TREATMENT

blog article

Mar 14, 2018

Precision medicine is at the forefront of innovative cancer treatment, targeting specific changes in a patient’s tumour DNA to treat, or even maybe one day prevent, the disease while also taking into account genetic variations between individuals, along with environmental and lifestyle factors...

Read More

Latest edition of Pharmaceutical Trademarks: A Global Guide now available LATEST EDITION OF PHARMACEUTICAL TRADEMARKS: A GLOBAL GUIDE NOW AVAILABLE

blog article

Mar 13, 2018

The seventh edition of Pharmaceutical Trademarks: A Global Guide, which provides trademark professionals with comprehensive guidance on the key issues involved in the protection, enforcement and marketing of pharmaceutical brands, is now available to view online. In its Pharma 2020 series, PwC estim...

Read More

Pond Virus Cures Patient POND VIRUS CURES PATIENT'S ANTIBIOTIC-RESISTANT INFECTION

blog article

Mar 12, 2018

An 80-year old doctor was stricken by a deadly bacterial infection, and doctors stopped it with a virus taken from a pond in Connecticut. In what seems like the plot of a movie, the virus, a type of bacteriophage, had been found to have an affinity for Pseudomonas aeruginosa. That same bacterium was...

Read More

Treating Hearing Loss: A Set of Inhibiting Drugs Provide Promising Results TREATING HEARING LOSS: A SET OF INHIBITING DRUGS PROVIDE PROMISING RESULTS

blog article

Mar 12, 2018

Our inner ears contain roughly 30,000 tiny hair cells that work to detect sound waves as well as to translate these waves into nerve signals. The nerve signals allow us to hear everyday sounds from speeches to music. However, any damage to the hair cells leads to hearing loss, a condition that affec...

Read More

New Report Links Opioid Prescriptions to Pharmaceutical Payouts to Doctors NEW REPORT LINKS OPIOID PRESCRIPTIONS TO PHARMACEUTICAL PAYOUTS TO DOCTORS

blog article

Mar 11, 2018

President Donald Trump has called for the death penalty for drug dealers. But would that include doctors and pharmaceutical company CEOs? A new report by CNN based on analysis conducted with Harvard researchers has found a direct link between opioid manufacturers and large payouts to doctors who pre...

Read More

Some ibuprofen users exceed daily NSAID dose limit SOME IBUPROFEN USERS EXCEED DAILY NSAID DOSE LIMIT

blog article

Mar 09, 2018

Exceeding the recommended daily dose of non-steroidal anti-inflammatory drugs (NSAIDs) can have considerable side effects, such as increased risk of gastrointestinal bleeding. However, limited data are available on how often the daily limit is exceeded. In Pharmacoepidemiology & Drug Safety (26 ...

Read More

BenevolentAI claims AI first with new Cambridge facility BENEVOLENTAI CLAIMS AI FIRST WITH NEW CAMBRIDGE FACILITY

blog article

Mar 08, 2018

The firm says its new facility on the Babraham Research Campus will “radically reduce the time it takes for drug candidates to enter clinical testing”. Ken Mulvany, founder and chairman of BenevolentAI, said: "We have built an artificial intelligence technology that can read and und...

Read More

Handling Potent Active Pharmaceutical Ingredients HANDLING POTENT ACTIVE PHARMACEUTICAL INGREDIENTS

blog article

Mar 06, 2018

The World Health Organization (WHO) defines an active pharmaceutical ingredient (API) as: “Any substance or combination of substances used in a finished pharmaceutical product (FPP), intended to furnish pharmacological activity or to otherwise have direct effect in the diagnosis, cure, mitigat...

Read More

Could a pharma company shun sales reps and be successful? COULD A PHARMA COMPANY SHUN SALES REPS AND BE SUCCESSFUL?

blog article

Feb 26, 2018

Matt Lowe, pharma agency veteran and founder (just this week) of healthtech agency performance.io, believes that such a company, relying heavily on search and performance marketing, may be a possiblity in the next few years (albeit once somebody has the courage to take the leap). I spoke to Lowe abo...

Read More

What Happened to the Plans for a Smart Contact Lens for Diabetics? WHAT HAPPENED TO THE PLANS FOR A SMART CONTACT LENS FOR DIABETICS?

blog article

Jan 25, 2018

Originally projected to be on the market by 2020, excitement about the contact lens to measure glucose levels from Novartis and Google has waned. Why? In 2016, smart wearables growth was steady but a recent study predicts that the market will pick up this year introducing innovative products to the ...

Read More

Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy YET MORE GOOD NEWS FOR GW PHARMA’S CANNABINOID DRUG AGAINST EPILEPSY

blog article

Jan 25, 2018

GW Pharmaceuticals has achieved encouraging Phase III results for Epidiolex, which have been published in leading scientific journal, The Lancet. The company’s lead candidate is being developed for the treatment of epilepsy – a condition characterized by the abnormal firing of neurons in...

Read More

Big Pharma Suppliers Are Dumping Toxic Waste in the Environment, Investor Alleges BIG PHARMA SUPPLIERS ARE DUMPING TOXIC WASTE IN THE ENVIRONMENT, INVESTOR ALLEGES

blog article

Jan 24, 2018

A Swedish investor is pressing the world’s biggest drug companies to be transparent about their supply chains, after it alleged that some suppliers to those firms were dumping toxic waste into the environment. Nordea Asset Management, the investment arm of the Nordic region’s largest ban...

Read More

Biotech and Pharma Boost R&D and Slow Sales to Beat Antibiotic Resistance BIOTECH AND PHARMA BOOST R&D AND SLOW SALES TO BEAT ANTIBIOTIC RESISTANCE

blog article

Jan 24, 2018

Antibiotics are becoming ineffective at an alarming rate due to our misuse in healthcare, animals, and crops. Antibiotic resistance is responsible for 700,000 deaths each year, which is expected to continue rising – overtaking cancer by 2050. To slow this trend, we must start to use these drug...

Read More

Pharma Companies PHARMA COMPANIES' EFFORTS TO ADDRESS DRUG-RESISTANT INFECTIONS

blog article

Jan 23, 2018

An independent analysis of pharmaceutical industry efforts to tackle drug resistance finds that, as well as developing new drugs, companies are also dismantling the incentives that encourage sales staff to oversell antibiotics, setting limits on the concentration of antibiotics in factory wastewater...

Read More

Drug Synthesis In Printed Reactors DRUG SYNTHESIS IN PRINTED REACTORS

blog article

Jan 23, 2018

I’m still trying to get my bearings with this new paper from the Cronin group at Glasgow. What it proposes is a new style of API (active pharmaceutical ingredient) production. Instead of being done in bench- or process-scale lab glassware or in production-plant reactors, these syntheses take p...

Read More

Artificial Intelligence in Pharmacy: Are You Ready? ARTIFICIAL INTELLIGENCE IN PHARMACY: ARE YOU READY?

blog article

Jan 22, 2018

Pharmacy as a profession and business continues to face challenges, and how it contributes value to the overall healthcare industry will determine its ongoing success. A key component of that may turn out to be effective use of technology, specifically artificial intelligence.

Read More

Successful Trial in Antibody Treatment of HIV SUCCESSFUL TRIAL IN ANTIBODY TREATMENT OF HIV

blog article

Jan 19, 2018

A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV neutralising antibody, called 10-1074, in humans. The results of the trial have just been published...

Read More

Hospitals Making Drugs? HOSPITALS MAKING DRUGS?

blog article

Jan 19, 2018

This story from the New York Times got a lot of attention yesterday, and understandably so. It’s fundamentally about the shortage of some generic drugs, a problem that’s been with us for some years now in one form or another. My own belief is that much of this is a regulatory problem, an...

Read More

Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference DRUG DEVELOPMENT INSIGHTS FROM THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

blog article

Jan 19, 2018

The 2018 J.P. Morgan Healthcare Conference, held in San Francisco from January 8-11, came and went in a whirlwind. In just a few days, there were hundreds of speeches, presentations, panels and a tremendous amount of networking. The conference was devoted to the business of healthcare, with announce...

Read More

Translational Medicine, Data Access and Pharmaceutical Innovation TRANSLATIONAL MEDICINE, DATA ACCESS AND PHARMACEUTICAL INNOVATION

blog article

Jan 17, 2018

Some of the early seeds of translational medicine were planted in 1992 when the U.S. National Cancer Institute introduced a program designed to improve and accelerate the knowledge exchange between basic and clinical science. Originally meant to address the slow growth of progress in cancer research...

Read More

A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology A CURE FOR CANCER? HOW CAR-T THERAPY IS REVOLUTIONIZING ONCOLOGY

blog article

Jan 16, 2018

CAR-T therapy has been hailed as a cure for cancer, but what really is this “miraculous technology” and what can we actually expect from it? The field of immuno-oncology is booming with billions of euros in investment. The ability to rewire our own immune system to fight cancer has certa...

Read More

Regulators Adjust to Better Meet Pharma Market Needs REGULATORS ADJUST TO BETTER MEET PHARMA MARKET NEEDS

blog article

Jan 16, 2018

Christine M. V. Moore, Ph.D., Global Head and Executive Director, Merck & Co-led “Changes in the Regulatory Landscape,” an education session held 31 October during the 2017 ISPE Annual Meeting & Expo. The first speaker, Ellen F. Morrison, Assistant Commissioner of Medical Product...

Read More

How FarmaTrust Plans to Revolutionize the Pharmaceutical Sector Using Blockchain HOW FARMATRUST PLANS TO REVOLUTIONIZE THE PHARMACEUTICAL SECTOR USING BLOCKCHAIN

blog article

Jan 15, 2018

Clever applications of blockchain technologies have the potential to fundamentally change lives. For instance, FarmaTrust, a highly anticipated and fast-growing startup, has developed an intelligent platform that, across a wide variety of features, optimizes the pharmaceutical industry by eliminatin...

Read More

Drug Pricing Dominates Senate Hearing on HHS Nominee Azar DRUG PRICING DOMINATES SENATE HEARING ON HHS NOMINEE AZAR

blog article

Jan 10, 2018

If confirmed as the next secretary of the Department of Health and Human Services (HHS), Alex Azar says that a top priority is to make drugs more affordable. He agreed with members of the Senate Finance Committee at his confirmation hearing January 9 that “drug prices are too high,” but ...

Read More

Rational drug design: How far have we come? RATIONAL DRUG DESIGN: HOW FAR HAVE WE COME?

blog article

Jan 08, 2018

From the early use of Hansch parameters and Topliss Trees to today’s computational structure–activity techniques, medicinal chemists have long sought to rationalise drug design to find the quickest and most resource-efficient route to market. But while modern strategies are more reliant ...

Read More

Why you should work for a pharma start-up WHY YOU SHOULD WORK FOR A PHARMA START-UP

blog article

Jan 04, 2018

If we look at Aerie Pharmaceuticals and their new products Rhopressa and Roclatan, these are designed to reduce elevated intraocular pressure (IOP), the cause of vision loss in open-angle glaucoma. This is the largest prescription market in ophthalmology and it’s amazing to see such a breakthr...

Read More

Pharma startup combines AI with cell images to target disease PHARMA STARTUP COMBINES AI WITH CELL IMAGES TO TARGET DISEASE

blog article

Jan 04, 2018

For centuries, modern medicine has grappled with the problem of finding the right drug treatment for the correct disease. While incremental progress is made every year, the lag time and expense of bringing a drug successfully to market have frustrated doctors, scientists, and patients. In search of ...

Read More

Cancer Drug Raises Risk of Cardiovascular Toxicity CANCER DRUG RAISES RISK OF CARDIOVASCULAR TOXICITY

blog article

Jan 01, 2018

A drug approved by the FDA in 2012 to treat a type of cancer called multiple myeloma has dangerous side effects that involve the heart. The drug is called carfilzomib, and it is a proteasome inhibitor now linked to an increased risk of dangerous heart events. High blood pressure, heart failure, hear...

Read More

NCI Director: AI Improves Cancer Research and Care NCI DIRECTOR: AI IMPROVES CANCER RESEARCH AND CARE

blog article

Jan 01, 2018

National Cancer Institute (NCI) Director Dr. Norman “Ned” Sharpless thinks artificial intelligence (AI), machine learning and big data can aid cancer researchers and caregivers. In fact, big data, along with basic research and the process of translating findings directly into treatments ...

Read More

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner SCHIZOPHRENIA AND DRUG DELIVERY BIOTECHS SIGN A MAJOR PHARMA PARTNER

blog article

Dec 19, 2017

Santa Claus is not the only busy one in the weeks leading up to Christmas this year, with Boehringer Ingelheim signing collaborations with Autifony and Evox Therapeutics. In the last couple of days, Boehringer Ingelheim has agreed to collaborate with two exciting British biotechs. On Monday, a deal ...

Read More

Prescription pharmaceutical misuse on the rise PRESCRIPTION PHARMACEUTICAL MISUSE ON THE RISE

blog article

Dec 19, 2017

A new report from the Australian Institute of Health and Welfare, Non-medical use of pharmaceuticals: trends, harms, and treatment: 2006-07 to 2015-6, shows that the number of Australians misusing pharmaceutical drugs is rising. The report looks at two main types of pharmaceuticals: opioid analgesic...

Read More

Pharmaceutical Company Pleads Guilty to Misbranding Oncology Drugs PHARMACEUTICAL COMPANY PLEADS GUILTY TO MISBRANDING ONCOLOGY DRUGS

blog article

Dec 19, 2017

Executives of AmerisourceBergen Specialty Group (ABSG), a wholly-owned subsidiary of AmerisourceBergen Corporation (ABC), pled guilty in September 2017 to illegally distributing misbranded drugs. The criminal charges stemmed from ABSG’s behavior between 2001 and 2014. Two of its subsidiaries, ...

Read More

PRESCRIPTION DRUG TRENDS PRESCRIPTION DRUG TRENDS

blog article

Dec 12, 2017

A gene therapy treatment recently approved by the Food and Drug Administration for use against leukemia is priced at $475,000 for a one-time treatment.1 While it’s exciting that new treatments, including prescription drugs, appear to be getting closer to curing society’s most lethal dise...

Read More

Critical Care: New Guidance for Medication Safety in the ICU CRITICAL CARE: NEW GUIDANCE FOR MEDICATION SAFETY IN THE ICU

blog article

Dec 11, 2017

The Society of Critical Care Medicine (SCCM) is committed to “Right Care, Right Now.”As part of this commitment, SCCM identifies patient care needs that require evidence-based best practice guidelines and works with experts to advance practices. Earlier this year, we published” Cli...

Read More

Social Media Influencers in Healthcare and Pharma: What’s Their Role? SOCIAL MEDIA INFLUENCERS IN HEALTHCARE AND PHARMA: WHAT’S THEIR ROLE?

blog article

Dec 04, 2017

Looking to social media influencers for advice makes sense when you’re shopping for fashionable jeans, your next great vacation, or even inspiration for your fitness regime. Most retail brands agree. According to the research firm L2 Gartner, 70% of retail brands are working with influencers t...

Read More

Formulation development of solid pharmaceuticals FORMULATION DEVELOPMENT OF SOLID PHARMACEUTICALS

blog article

Nov 30, 2017

For many decades, Bosch Pharma Service’s customers have benefited from our know-how in the production of solid pharmaceuticals – not only for the design and construction of machines and facilities and the production of solid pharmaceuticals but also for the products manufactured using th...

Read More

Will Pharma Reach a Negative Return on its R&D Investments? WILL PHARMA REACH A NEGATIVE RETURN ON ITS R&D INVESTMENTS?

blog article

Nov 30, 2017

Pharma depends on innovation, which is why it turns to biotech as the powerhouse of novel technologies. About 65% of recently drugs come from small life sciences companies according to a report from HBM Partners.

Read More

Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout GALAPAGOS CYSTIC FIBROSIS DRUG ENTERS PHASE I, TRIGGERING €8.5M PAYOUT

blog article

Nov 22, 2017

Galapagos is a clinical-stage biotech developing small molecule medicines for a range of indications. It partnered up with the global pharma company, AbbVie, back in 2013, to develop a number of cystic fibrosis (CF) candidates for a combination therapy.

Read More

How Medical Scribes Are Helping To Improve Patient Care HOW MEDICAL SCRIBES ARE HELPING TO IMPROVE PATIENT CARE

blog article

Nov 20, 2017

Medical scribes are one of the lesser known roles in the healthcare industry. They are an essential component, however, and their arrival has brought with it numerous benefits to institutions and to patients. Medical scribes are an increasingly common sight in doctors’ offices up and down the ...

Read More

As Drug Development Costs Skyrocket, AI Offers Some Hope AS DRUG DEVELOPMENT COSTS SKYROCKET, AI OFFERS SOME HOPE

blog article

Nov 20, 2017

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics.

Read More

A Practical Approach to the Challenges of Pediatric Drug Development A PRACTICAL APPROACH TO THE CHALLENGES OF PEDIATRIC DRUG DEVELOPMENT

blog article

Nov 17, 2017

Drug developers can’t take an adult clinical trial protocol and simply retool it for pediatrics. Yet, in my work at a pediatric clinical research organization (CRO), I frequently see sponsors attempt to do just that. Successfully implementing a pediatric drug development plan poses challenges ...

Read More

Myelo Therapeutics Takes on Unmet Needs in Cancer MYELO THERAPEUTICS TAKES ON UNMET NEEDS IN CANCER

blog article

Nov 17, 2017

Many pharmaceutical and biotechnology start-ups have been founded for the purpose of taking on unmet needs. It has often been difficult for the larger, more established pharma companies to focus on these narrower problems, so the leaner.

Read More

How in vitro assays and drug metabolism are being used to de-risk drug development HOW IN VITRO ASSAYS AND DRUG METABOLISM ARE BEING USED TO DE-RISK DRUG DEVELOPMENT

blog article

Nov 16, 2017

If all molecules in discovery and development were added together over recent years and compared to the number of successful drug approvals each year, the ratio is (approximately) 10,000:1. In other words, for every 10,000 molecules entering drug discovery, 9,999 will fail during some stage of the d...

Read More

The Convergence of Digital Health, Devices and Pharma THE CONVERGENCE OF DIGITAL HEALTH, DEVICES AND PHARMA

blog article

Nov 15, 2017

There has been a huge push in policy circles to speed innovation in medicine which is manifest in several initiatives, including most notably the 21st Century Cures Act implementation. But it would be a mistake to assess the quickening pace of innovation solely through the lens of policy.

Read More

City sues drug giants CITY SUES DRUG GIANTS

blog article

Nov 14, 2017

City Hall filed a lawsuit on Nov. 7 against Purdue Pharma and other pharmaceutical manufacturers and distributors, alleging that they are contributing to the opioid crisis in New Haven.

Read More

Encourage Your Patients to Be Active Participants ENCOURAGE YOUR PATIENTS TO BE ACTIVE PARTICIPANTS

blog article

Nov 14, 2017

Patient engagement has all the intentions to improve the ability of every patient to create meaningful and solid relationships with their healthcare providers. When patients can have meaningful relationships with their healthcare providers, this will create the way for them to participate actively w...

Read More

Pharma in the Digital Age PHARMA IN THE DIGITAL AGE

blog article

Nov 14, 2017

We are living in a digital age, and this results in more patients being less depending on their health care providers for advice and information. More patients are now able to take more control of their lives and their health.

Read More

Pharmaceutical Industry Profits And Research And Development PHARMACEUTICAL INDUSTRY PROFITS AND RESEARCH AND DEVELOPMENT

blog article

Nov 13, 2017

When the challenge of affording prescription drugs is raised, pharmaceutical manufacturers often argue that steps to reduce prices will lead to less innovation in the future. This response presumably applies to policies that use the market, such as shortening periods of exclusivity and making approv...

Read More

Governments Mount Opioid Lawsuit Wave at Purdue Pharma GOVERNMENTS MOUNT OPIOID LAWSUIT WAVE AT PURDUE PHARMA

blog article

Nov 10, 2017

Governments are swamping Purdue Pharma, makers of OxyContin, with opioid lawsuits alleging the company is responsible for the costs of opioid overdose.The continuing wave of opioid lawsuits coming at the makers of OxyContin, Purdue Pharma, based in Stamford, Connecticut, is growing. Recently, 28 Wis...

Read More

Drug Companies Collaborate to Take on the Opioid Crisis DRUG COMPANIES COLLABORATE TO TAKE ON THE OPIOID CRISIS

blog article

Nov 08, 2017

The opioid crisis in the US is now responsible for taking more American lives each year than car crashes. The pharmaceutical industry has come under fire for having a role in the epidemic, with some companies being accused of deliberately downplaying the addictive dangers of opioids.

Read More

Drug Companies Collaborate to Take on the Opioid Crisis DRUG COMPANIES COLLABORATE TO TAKE ON THE OPIOID CRISIS

blog article

Nov 08, 2017

The opioid crisis in the US is now responsible for taking more American lives each year than car crashes.The pharmaceutical industry has come under fire for having a role in the epidemic, with some companies being accused of deliberately downplaying the addictive dangers of opioids.

Read More

Egyptian-American fund announces new pharmaceutical investment EGYPTIAN-AMERICAN FUND ANNOUNCES NEW PHARMACEUTICAL INVESTMENT

blog article

Nov 07, 2017

The Egyptian-American Enterprise Fund (EAEF) signed an agreement to acquire a minority stake in Orchidia Pharmaceutical Industries, the company announced in a statement earlier this week.

Read More

Pharma’s digital patient engagement innovators identified PHARMA’S DIGITAL PATIENT ENGAGEMENT INNOVATORS IDENTIFIED

blog article

Nov 06, 2017

Pharmaceutical companies are making more of an effort to engage with European patients through digital challenges, but their success in doing so varies as a small handful of innovators starts to emerge. Decision Resources Group (DRG) identified Novartis, Pfizer and Sanofi as best-in-class when it ca...

Read More

8 Things That Could Go Wrong With Your Pharma Marketing Campaign 8 THINGS THAT COULD GO WRONG WITH YOUR PHARMA MARKETING CAMPAIGN

blog article

Nov 06, 2017

Pharma marketing can sometimes feel like a thankless job  the web of overlapping indications, “second plus”-line treatments, FDA regulations and privacy landmines sapping the joy out of even seasoned industry veterans.

Read More

The Fine Line of Pharma & Patient Group Collaboration THE FINE LINE OF PHARMA & PATIENT GROUP COLLABORATION

blog article

Nov 06, 2017

A new attempt by European drug firms and patient organizations to chart a course between cooperation and cooption has highlighted the scale of the challenges that healthcare stakeholders face when they reach out to one another.

Read More

Europe Bio Pharmaceuticals Market Distribution and Key Players Analysis to 2021 EUROPE BIO PHARMACEUTICALS MARKET DISTRIBUTION AND KEY PLAYERS ANALYSIS TO 2021

blog article

Nov 06, 2017

According to the report Europe Bio Pharmaceuticals Market, published by Market Data Forecast, the Europe market is projected to reach USD 56.83 billion by 2021, at a CAGR of 8.89% from 2016 to 2021. Primarily biopharmaceuticals products are obtained from life forms or genetically modified plants and...

Read More

The Drug Project Landscape THE DRUG PROJECT LANDSCAPE

blog article

Nov 03, 2017

Here’s a new paper in Nature Reviews Drug Discovery that’s going to the trouble of matching specific disease indications with specific mechanisms in drug projects over the last 20 years (both the successful ones and the unsuccessful ones).

Read More

Non-core divestments in pharma could herald an increase in IP-rich deal making NON-CORE DIVESTMENTS IN PHARMA COULD HERALD AN INCREASE IN IP-RICH DEAL MAKING

blog article

Nov 02, 2017

Merck Group, Pfizer and Eli Lilly have, in quick succession, announced that they are considering moves to sell large, non-core parts of their businesses. Intellectual property, and its valuation, would inevitably play a large part in such transactions. But perhaps more significantly, the pressures f...

Read More

Complex Generic Drug Products: A Changing Regulatory Landscape COMPLEX GENERIC DRUG PRODUCTS: A CHANGING REGULATORY LANDSCAPE

blog article

Nov 01, 2017

Earlier this year, the U.S. Food and Drug Administration (FDA) announced its Drug Competition Action Plan, which aims to bring more competition to the drug market and improve consumer access to drugs. As part of this effort, the Agency is focusing on ways to help bring complex generic drugs to marke...

Read More

Pharma on Mars: Getting Drugs Ready for Deep Space Travel PHARMA ON MARS: GETTING DRUGS READY FOR DEEP SPACE TRAVEL

blog article

Nov 01, 2017

When we think of the challenges of space travel, we tend to focus on the technological aspects involving the difficulty of launch and landing, the structural integrity of the spacecraft and the basic safety of the astronauts.

Read More

FDA Explores Flexible Drug Marketing Policies FDA EXPLORES FLEXIBLE DRUG MARKETING POLICIES

blog article

Nov 01, 2017

FDA regulation of prescription drug and medical product promotion has come under fire in recent years, as federal courts have supported industry challenges to rules limiting communications of unapproved drug uses.

Read More

Pharmaceutical Filtration Devices Market: Comprehensive Industry Analysis & Global Foresight to 2022 PHARMACEUTICAL FILTRATION DEVICES MARKET: COMPREHENSIVE INDUSTRY ANALYSIS & GLOBAL FORESIGHT TO 2022

blog article

Nov 01, 2017

Globally, Pharmaceutical filtration Devices Market is growing rapidly and it is anticipated to show an exponential growth reaching approximately $23 Billion in 2022. Filtration in pharmaceutical has been used to purify or separate the component and also to maintain the sterile conditions during the ...

Read More

Did Amazon Just Create a Solution to Pharma’s Last Mile Problem? DID AMAZON JUST CREATE A SOLUTION TO PHARMA’S LAST MILE PROBLEM?

blog article

Oct 31, 2017

Amazon just announced a new program that would allow delivery people into a person’s house. While this may help solve the problem of items being stolen off people’s porches and could make delivery of items that require signatures such as iPhones easier, it may also be another piece to Am...

Read More

Trump TRUMP'S STUNNING NEW IDEA TO STOP THE OPIOID CRISIS: JUST SAY NO

blog article

Oct 26, 2017

Donald Trump appealed to his late brother’s struggle with addiction while declaring the opioid crisis a national public health emergency Thursday afternoon, an issue he plans to tackle in part by employing “really tough, really big advertising,” telling kids in a very serious voice...

Read More

Biggest Blunders Pharma Marketers Make (And How To Correct Them) BIGGEST BLUNDERS PHARMA MARKETERS MAKE (AND HOW TO CORRECT THEM)

blog article

Oct 25, 2017

According to India Brand Equity Foundation, close to 80% of all medicines in India are prescription-based. This establishes doctors as the number one customer group of pharma marketers. Effective physician engagement, therefore, becomes the holy grail of pharma marketing success. However, the market...

Read More

Design, formulation and manufacture of film-coated drug products DESIGN, FORMULATION AND MANUFACTURE OF FILM-COATED DRUG PRODUCTS

blog article

Oct 25, 2017

Film coating is a common step in tablet manufacture that can be used to improve product appearance, organoleptic properties, or to facilitate swallowing. Functional film coats can also be used as a part of the product’s stabilisation strategy and to modify or delay drug release.

Read More

Harnessing Patient Communities for Pharma Marketing HARNESSING PATIENT COMMUNITIES FOR PHARMA MARKETING

blog article

Oct 23, 2017

What do people do when they are sick? Often, even before they call a doctor, they go online. And when they’re facing a health crisis or ongoing illness, more people than ever are turning to social media and online communities before, during, and after diagnosis.

Read More

Building a Patient-Centered Pharmacy Immunization Service BUILDING A PATIENT-CENTERED PHARMACY IMMUNIZATION SERVICE

blog article

Oct 23, 2017

Critically important to the success of population health are vaccines that immunize children and adults against diseases like the flu, hepatitis B, measles, mumps, pneumonia and tetanus. With this growing need for effective immunization programs to manage population health, the American Pharmacists ...

Read More

The European Regulatory Landscape for Pediatric Drug Development THE EUROPEAN REGULATORY LANDSCAPE FOR PEDIATRIC DRUG DEVELOPMENT

blog article

Oct 20, 2017

In my 35 years of working to develop safer, more effective medications for children, I’ve often been asked about how to navigate the regulatory landscape in the US and Europe. In a previous blog post, I discussed the latest FDA trends regarding pediatric drug development. In this blog, I&rsquo...

Read More

Stability testing requirements for Pharmaceuticals and Medical Devices STABILITY TESTING REQUIREMENTS FOR PHARMACEUTICALS AND MEDICAL DEVICES

blog article

Oct 19, 2017

Accelerated stability tests provide a means of comparing alternative formula-dons, packaging materials, and/or manufacturing processes in short-term experiments. As soon as the final formulation and manufacturing process have been established, the manufacturer carries out a series of accelerated sta...

Read More

FDA approves new robotic surgery device FDA APPROVES NEW ROBOTIC SURGERY DEVICE

blog article

Oct 17, 2017

US regulators have approved a new robotic surgery device for use in colorectal and gynecological operations. TransEnterix Surgical’s computer-assisted surgical S enhance System allows surgeons to sit at a console unit or cockpit that provides a 3-D high-definition view of the surgical field.

Read More

New Rwanda Pharmaceutical Lab  To Test 100 Drug Types NEW RWANDA PHARMACEUTICAL LAB TO TEST 100 DRUG TYPES

blog article

Oct 17, 2017

Rwanda is upgrading its pharmaceutical laboratory to give it a capacity to test more strong drugs. By December this year, the newly introduced ‘Medical and pharmaceutical laboratory’ will have the capacity to test 100 types of medicine from 35 types since July when the laboratory started...

Read More

A paradigm change in biologics microbiological contaminant control A PARADIGM CHANGE IN BIOLOGICS MICROBIOLOGICAL CONTAMINANT CONTROL

blog article

Oct 17, 2017

Even with the advent of biologics, the historical paradigm of microbiological control has largely continued on this path. The testing of artefacts that more specifically activate the adaptive immune system without setting off proinflammatory responses has taken place only recently.

Read More

Pharma and medtech industries prepare for hard Brexit PHARMA AND MEDTECH INDUSTRIES PREPARE FOR HARD BREXIT

blog article

Oct 16, 2017

Drugmakers and medical devices companies are drawing up plans to protect supply chains in case Britain crashes out of the European Union without a trade deal, and some small service businesses are already relocating to stay inside the bloc.

Read More

What does your pharma brand mean to patients? WHAT DOES YOUR PHARMA BRAND MEAN TO PATIENTS?

blog article

Oct 16, 2017

During the course of our research last summer, we had the opportunity to talk with patients and caregivers about the branding aspect of their prescription drugs. While branding is considered an important part of the marketing mix when it comes to launching a product, most patients don’t feel an affi...

Read More

Can Streamlined R&D Reduce Drug Prices? CAN STREAMLINED R&D REDUCE DRUG PRICES?

blog article

Oct 11, 2017

The recent FDA approval of the first chimeric antigen receptor T cell (CAR-T) therapy to treat young patients with a serious form of leukemia reignited charges that high drug prices limit patient access to life-saving medicines.

Read More

Manufacturing Generic Versions of Controlled Substances MANUFACTURING GENERIC VERSIONS OF CONTROLLED SUBSTANCES

blog article

Oct 09, 2017

Last Fall, we were pleased to announce that PCI Synthesis received DEA registration for controlled substance development and manufacturing, and we invested in new systems, processes, and training in order to manufacture controlled substances in our Newburyport facility.

Read More

Community Oncology Practices as Clinical Trial Partners COMMUNITY ONCOLOGY PRACTICES AS CLINICAL TRIAL PARTNERS

blog article

Oct 09, 2017

Pharmaceutical manufacturers developing new cancer drugs and community oncology practices seeking new therapies for patients are ideal clinical trial partners. In my previous blog post, I described how community oncology practices can access clinical trials and optimize their participation to drive ...

Read More

DSCSA: 2017 Deadline for Prescription Drug Manufacturers Fast Approaching DSCSA: 2017 DEADLINE FOR PRESCRIPTION DRUG MANUFACTURERS FAST APPROACHING

blog article

Oct 05, 2017

The Drug Supply Chain Security Act (DSCSA) is approaching full implementation, and companies at all levels of the pharmaceutical supply chain have to take note. Regulators put this system in place to ensure the traceability of prescription drugs all the way from their manufacture to end use.

Read More

Members of Congress Side-Eye Pharma Company for Patent Shenanigans MEMBERS OF CONGRESS SIDE-EYE PHARMA COMPANY FOR PATENT SHENANIGANS

blog article

Oct 05, 2017

Congress is taking drug company Allergan to task for a bizarre legal scheme that involves using a Native American tribe as a shield against patent challenges. On Sept. 8, the pharmaceutical maker announced that it would be transferring disputed patents for Restasis, a dry-eye drug, to the Saint Regi...

Read More

Epigenetic drugs show promise as antivirals EPIGENETIC DRUGS SHOW PROMISE AS ANTIVIRALS

blog article

Oct 05, 2017

Some epigenetic pharmaceuticals have the potential to be used as broad-spectrum antivirals, according to a new study. The study demonstrated that histone methyltransferases EZH2/1 inhibitors, which are being used in cancer clinical trials, have activity against a variety of viruses, including herpes...

Read More

Shining the light on drug-drug interactions (DDI) SHINING THE LIGHT ON DRUG-DRUG INTERACTIONS (DDI)

blog article

Oct 04, 2017

Advancements in vitro technologies and analytical instrumentation over the past decade allow scientists to apply a variety of in vitro based assays designed to rapidly assess risk-liability, such as drug-drug interactions (DDI), one of the factors contributing to both current high attrition rates an...

Read More

California Takes On Drug Pricing: Real Progress Or Illusion? CALIFORNIA TAKES ON DRUG PRICING: REAL PROGRESS OR ILLUSION?

blog article

Oct 02, 2017

Californians and others around the country following the California legislature’s multiyear debate on prescription drug pricing may have stood up and taken notice on September 13 when the state Senate followed the Assembly in passing SB-17 to facilitate greater transparency in brand-name and generic...

Read More

The Importance of Selecting the Most Promising Drug Target THE IMPORTANCE OF SELECTING THE MOST PROMISING DRUG TARGET

blog article

Sep 27, 2017

The growing economic pressure due to late-stage drug approval failures has been forcing drug discovery and development scientists to adapt their strategies in order to increase their chances of success. While it’s important to optimize drug candidates with respect to pharmacokinetics, efficacy and t...

Read More

Cipla Europe: one more Pharma Laboratory that is added to ebuyfarma CIPLA EUROPE: ONE MORE PHARMA LABORATORY THAT IS ADDED TO EBUYFARMA

blog article

Sep 25, 2017

Cipla Europe: one more Pharma Laboratory that is added to our platform B2B Cipla is a leader pharmaceutical company with global presence, dedicated to manufacture medicines of high quality, including brands and generics, present in the India, south Africa, states united and emerging countries. It is...

Read More

Is the Pharma Industry Missing the Big Picture? IS THE PHARMA INDUSTRY MISSING THE BIG PICTURE?

blog article

Sep 22, 2017

There is a disconnect between how drugs are developed and how they are used. In the traditional method of target-oriented development, each new candidate drug is scrutinized in a handful of interactions with desirable and undesirable targets.

Read More

More than 85 medicines in development for Alzheimer’s disease MORE THAN 85 MEDICINES IN DEVELOPMENT FOR ALZHEIMER’S DISEASE

blog article

Sep 21, 2017

When Brian Kursonis started “blanking out” for moments at a time, a scan revealed plaques of a protein called amyloid in the brain, one sign of Alzheimer’s disease. A test of his spinal fluid found high levels of amyloid and tau, another protein linked to the condition.

Read More

What is immuno-oncology? Uncovering the future of cancer therapy WHAT IS IMMUNO-ONCOLOGY? UNCOVERING THE FUTURE OF CANCER THERAPY

blog article

Sep 20, 2017

Hailed as one of the most exciting and unique cancer treatments of today, here’s everything you need to know about this medical marvel. The definition of immunotherapy is the use of the body’s natural defences (immune system) to fight disease. What is immuno-oncology? Immuno-oncology is a type of im...

Read More

Thousands of pharmacies at a click: the revolution in pharmaceutical distribution comes hand in hand with the launch "ebuyfarma" THOUSANDS OF PHARMACIES AT A CLICK: THE REVOLUTION IN PHARMACEUTICAL DISTRIBUTION COMES HAND IN HAND WITH THE LAUNCH "EBUYFARMA"

blog article

Sep 19, 2017

Well, today's pharmacies, as emerging companies, have a strong working relationship with technology. It is a new business model, with innovative ideas, that excel in the market to be supported by the applied sciences. Precisely, a startup is a human organization, with a strong technological componen...

Read More

ATMPs – patient-specific drugs on their way to market ATMPS – PATIENT-SPECIFIC DRUGS ON THEIR WAY TO MARKET

blog article

Sep 18, 2017

At the end of the last millennium, a new form of medicine was introduced that today, some 30 years later, likely appears to be fulfilling the promises made at that time. ATMP, “Advanced Therapy Medicinal Products“, delineate novel forms of therapy.

Read More

Adjudicating Cardiovascular Endpoints in Diabetic Kidney Disease Studies ADJUDICATING CARDIOVASCULAR ENDPOINTS IN DIABETIC KIDNEY DISEASE STUDIES

blog article

Sep 14, 2017

Diabetic kidney disease (DKD) patients have an increased cardiovascular (CV) risk in addition to their increased risk of progression to end-stage renal disease. Recognizing that the FDA and other regulatory agencies have great interest in both the CV and renal safety and efficacy of compounds under ...

Read More

The Challenges of Signal Detection in Spontaneous Reporting THE CHALLENGES OF SIGNAL DETECTION IN SPONTANEOUS REPORTING

blog article

Sep 13, 2017

Pharmacovigilance is essential to pharmaceutical businesses. It facilitates the correct use of a drug, safeguarding the drug as a meaningful treatment option when the benefits it offers outweigh known risks, or measures can be taken to mitigate those risks.

Read More

Reflections on the preregistration assessment REFLECTIONS ON THE PREREGISTRATION ASSESSMENT

blog article

Sep 12, 2017

With the current preregistration trainees starting to settle into their new roles, I thought it would be timely to reflect on the preregistration assessment after completing it myself this year. This is the second year of the new assessment format where the questions are scenario based; this encoura...

Read More

Pharma patent wars: Brilliant tactics; terrible optics PHARMA PATENT WARS: BRILLIANT TACTICS; TERRIBLE OPTICS

blog article

Sep 12, 2017

Whether or not you know it, or care to acknowledge it, a global war between the makers of branded drugs and generics has been going on for decades. In return for the expense of development, drug makers are granted patents that allow them exclusive rights to sell their products.

Read More

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace WHAT THEY ARE SAYING: STUDY ON CANCER R&D COSTS IS NOT AN ACCURATE REPRESENTATION OF MARKETPLACE

blog article

Sep 12, 2017

A recent study published in JAMA Internal Medicine provides flawed and inaccurate estimates of the significant research and development (R&D) investments made by biopharmaceutical companies to develop new cancer treatments and cures for patients. The study focuses on a selective sample of companies ...

Read More

What WHAT'S NEXT FOR INHALED MEDICATIONS AND INHALATION TECHNOLOGY?

blog article

Sep 11, 2017

Current estimates suggest that as many as 235 million people worldwide have asthma and over 200 million people have the chronic obstructive pulmonary disease (COPD). With rates set to increase, the need for efficacious medications for these incurable diseases is a major focus for research.

Read More

The Vital Role of Patient Advocacy in Charting the Future of Medicine THE VITAL ROLE OF PATIENT ADVOCACY IN CHARTING THE FUTURE OF MEDICINE

blog article

Sep 09, 2017

For many of us, it is not difficult to remember a time where the role of patient advocacy in science and medicine was far different, and much more limited, than it is today. Patient advocacy organizations were, by and large, relied upon to elevate awareness of their target illnesses, raise money and...

Read More

Resolution to Dissolution: Making Better Drugs RESOLUTION TO DISSOLUTION: MAKING BETTER DRUGS

blog article

Sep 08, 2017

There is a widening gap between the discovery of potential new drugs and their successful product development. Drugs are increasingly complex and diverge from Lipinski’s rule of 5, the industry standard for predicting a drug’s bioavailability and solubility. Contemporary literature reports that grea...

Read More

What to Do When the Microorganisms Get to You WHAT TO DO WHEN THE MICROORGANISMS GET TO YOU

blog article

Sep 06, 2017

For the first time, ever an injectable clinical batch has been manufactured with the help of single-use technologies. A great way of fighting unwanted contamination in drug development! Have you ever opened a petri-dish and found an unknown growth on your medium? The same medium you had carefully pr...

Read More

Expanding Treatment Options to Address Unmet Need in Blood Cance EXPANDING TREATMENT OPTIONS TO ADDRESS UNMET NEED IN BLOOD CANCE

blog article

Sep 05, 2017

Every three minutes, someone in the United States is diagnosed with a type of blood cancer. Blood cancers affect the production and function of blood cells and typically begins in bone marrow, where blood is produced. When blood cells become cancerous, uncontrolled growth of abnormal blood cells int...

Read More

ICYMI: Drug Pricing Bill Is Bad for Business, Patients ICYMI: DRUG PRICING BILL IS BAD FOR BUSINESS, PATIENTS

blog article

Sep 05, 2017

Researchers and biotech leaders continue to discover new cures and treatments that are making a positive difference in the lives of patients. But unfortunately, there are some policymakers in Washington D.C. and various state capitals who continue to push misguided proposals that will undermine biom...

Read More

Serialization, aggregation, coding formats – global challenges for the Pharma industry SERIALIZATION, AGGREGATION, CODING FORMATS – GLOBAL CHALLENGES FOR THE PHARMA INDUSTRY

blog article

Sep 01, 2017

According to the OECD, counterfeit medicines are responsible for more than 700,000 deaths annually. Up to 30% of all medicines are estimated to be fake in emerging and developing countries, says the World Health Organization (WHO). While fake drugs are potentially lethal, parallel markets and counte...

Read More

Selecting Anti-Melanoma Drug Targets SELECTING ANTI-MELANOMA DRUG TARGETS

blog article

Aug 28, 2017

Every year, hundreds of thousands of people are diagnosed with melanoma, the deadliest form of skin cancer. Although rates of melanoma have continued to rise over the last three decades, the traditional treatment—chemotherapy—has had limited effectiveness in fighting this aggressive cancer. As a res...

Read More

Pharmaceutical Data Integrity: Are Your Controls Tough Enough? PHARMACEUTICAL DATA INTEGRITY: ARE YOUR CONTROLS TOUGH ENOUGH?

blog article

Aug 25, 2017

As pharmaceutical supply chains have grown in complexity and international outsourcing becomes the new norm, the data used by drug developers and manufacturers to make decisions on production line design, quality control and batch release is coming under greater scrutiny from regulatory authorities....

Read More

What is pharmacovigilance and why is it important? WHAT IS PHARMACOVIGILANCE AND WHY IS IT IMPORTANT?

blog article

Aug 23, 2017

Pharmacovigilance is concerned with only two outcomes: safety and efficacy. Does a drug work and is it safe? It touches on almost every aspect of the drug lifecycle - from preclinical development to post-market surveillance - making it one of the most fundamental functions within a life science comp...

Read More

Insulin Pumps Pharmaceutical, Healthcare disease & Therapeutics Development & Drug Profile involved in the Pipeline Assessment 2017 INSULIN PUMPS PHARMACEUTICAL, HEALTHCARE DISEASE & THERAPEUTICS DEVELOPMENT & DRUG PROFILE INVOLVED IN THE PIPELINE ASSESSMENT 2017

blog article

Aug 22, 2017

The Medical Devices sector report, “Insulin Pumps – Medical Devices Pipeline Assessment, 2017″” provides an overview of Insulin Pumps currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of dev...

Read More

Growing and Testing Drugs on Dozens of Tiny Guts at Once GROWING AND TESTING DRUGS ON DOZENS OF TINY GUTS AT ONCE

blog article

Aug 18, 2017

In a demonstration of where the field of organ-on-a-chip technology is inevitably going, MIMETAS, a company developing organ-on-chip technology out of Leiden, The Netherlands, and Roche, the giant pharmaceutical company, teamed up to grow and test 350 perfused gut tubes within a matter of days. The ...

Read More

The Medicare drug benefit doesn’t need federal fixing THE MEDICARE DRUG BENEFIT DOESN’T NEED FEDERAL FIXING

blog article

Aug 16, 2017

In the 11-plus years since the Medicare Part D prescription drug benefit was implemented, at least two facts have remained inarguable. One is that the program has worked extremely well in making medications affordable and accessible for millions of Medicare beneficiaries, and the other is that there...

Read More

Diabetic Gastroparesis – Pharmaceutical & Healthcare disease Pipeline Review, H2 2017 DIABETIC GASTROPARESIS – PHARMACEUTICAL & HEALTHCARE DISEASE PIPELINE REVIEW, H2 2017

blog article

Aug 16, 2017

A new research document with title ‘Diabetic Gastroparesis – Pipeline Review, H2 2017’ covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis and important players/vendors such as Allergan Plc, Cempra Inc, Evoke Pharma Inc etc. The report wil...

Read More

Survey reveals the importance of standardized label management in the pharmaceutical industry SURVEY REVEALS THE IMPORTANCE OF STANDARDIZED LABEL MANAGEMENT IN THE PHARMACEUTICAL INDUSTRY

blog article

Aug 14, 2017

NiceLabel recently produced a survey in cooperation with Pharmaceutical Manufacturing on the state of label management in the pharmaceutical industry. One hundred key decision makers involved in the selection and purchase of label management systems in the pharma and biopharma were surveyed.

Read More

When will preprints take off in medicine? WHEN WILL PREPRINTS TAKE OFF IN MEDICINE?

blog article

Aug 14, 2017

Use of preprints, the public posting of research articles before peer-reviewed publication, is increasing rapidly, with the number of preprints posted to repositories each month almost doubling in the past year. Researchers post preprints to help quickly disseminate their latest scientific findings ...

Read More

Maximizing Real-World Data: Impact of Cardiovascular Disease on Clinical Outcomes in Rheumatoid Arthritis MAXIMIZING REAL-WORLD DATA: IMPACT OF CARDIOVASCULAR DISEASE ON CLINICAL OUTCOMES IN RHEUMATOID ARTHRITIS

blog article

Aug 14, 2017

The presence of CVD itself has been shown to increase the risk of death in RA patients by approximately 50%, and there is an emerging relationship between RA, CVD and the therapies used to treat them. The use of RA treatments such as tumor necrosis factor (TNF) inhibitors and methotrexate (MTX) may ...

Read More

News Recap: The Myth of Drug Expiration Dates NEWS RECAP: THE MYTH OF DRUG EXPIRATION DATES

blog article

Aug 11, 2017

Are drugs passed their expiration date safe and effective? That is the question that Lee Cantrell from the California Poison Control System and Roy Gerona a UCSF researcher set out to answer. While the duo knew that the term “expiration date” was a misnomer and is a date that the FDA and pharmaceut...

Read More

Regulatory Implications for the Pharmaceutical Industry in the Midst of the Opioid Abuse Crisis REGULATORY IMPLICATIONS FOR THE PHARMACEUTICAL INDUSTRY IN THE MIDST OF THE OPIOID ABUSE CRISIS

blog article

Aug 10, 2017

In the midst of an ongoing opioid epidemic in the United States, the Food and Drug Administration (FDA) asked Endo Pharmaceuticals to withdraw OPANA ER from the market in June 2017. This is the first time a sponsor has been asked to withdraw a marketed product for abuse reasons.

Read More

China Joins ICH in Pursuit of Global Harmonization of Drug Development Standards CHINA JOINS ICH IN PURSUIT OF GLOBAL HARMONIZATION OF DRUG DEVELOPMENT STANDARDS

blog article

Aug 09, 2017

Increasingly, drug development is a global endeavor. It requires international collaboration to ensure that consistent standards are adopted and adhered to by all drug makers and regulatory authorities, regardless of country of origin or destination. I am pleased to have been in China recently, when...

Read More

The Growing Role of Polymer Synthesis Driven by Modern Advances in Drug Delivery THE GROWING ROLE OF POLYMER SYNTHESIS DRIVEN BY MODERN ADVANCES IN DRUG DELIVERY

blog article

Aug 07, 2017

Not everyone knows what Polymer Synthesis is, but many have heard of new innovations in how drugs are delivered and absorbed into the body. Thanks to polymer synthesis, implantable devices are administering consistent medications into patients who sorely need them; those with pacemakers are being sp...

Read More

The Key Element for Pharma Brands to Manage Adverse Events: Partner with Pharmacovigilance THE KEY ELEMENT FOR PHARMA BRANDS TO MANAGE ADVERSE EVENTS: PARTNER WITH PHARMACOVIGILANCE

blog article

Aug 07, 2017

Brands that have successfully managed adverse events in social media have one thing in common: all have buy-in from their pharmacovigilance (PV) team. Below is a primer that all pharma marketers need to know about working with PV – and how to make the most of this crucial partnership.

Read More

Take The Generic Drug, Patients Are Told — Unless Insurers Say No TAKE THE GENERIC DRUG, PATIENTS ARE TOLD — UNLESS INSURERS SAY NO

blog article

Aug 07, 2017

It’s standard advice for consumers: If you are prescribed a medicine, always ask if there is a cheaper generic. Nathan Taylor, a 3-D animator who lives outside Houston, has tried to do that with all his medications. But when he fills his monthly prescription for Adderall XR to treat his attention-de...

Read More

Breakthrough in Drug 3D Printing BREAKTHROUGH IN DRUG 3D PRINTING

blog article

Jul 31, 2017

Recent strides in pharmaceutical 3D printing has revealed that not only does 3D printing take lesser time to produce, but also the new technique forms unique chemical structures that can potentially treat several ailments more effectively than conventionally manufactured drugs.

Read More

Big Data Pharmaceutical Advertising Market is expected to Reach $4.47 billion, Globally by 2023 BIG DATA PHARMACEUTICAL ADVERTISING MARKET IS EXPECTED TO REACH $4.47 BILLION, GLOBALLY BY 2023

blog article

Jul 31, 2017

The global Big Data Pharmaceutical Advertising market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly in the near future. Increasing expenditure on pharmaceutical advertising, growing trend of digital advertisement and effective use of ...

Read More

Generic Drug Competition Equals Consumer Price Relief GENERIC DRUG COMPETITION EQUALS CONSUMER PRICE RELIEF

blog article

Jul 31, 2017

Generic drugs make up about 88 percent of prescriptions filled in the United States, providing generally low-cost relief for the overwhelming majority of Americans who are presently afflicted with a variety of health-related maladies. A 2015 study published in the Journal of the American Medical Ass...

Read More

Bronchodilators Market: Increasing Growth Seen in Pharmaceuticals Sector BRONCHODILATORS MARKET: INCREASING GROWTH SEEN IN PHARMACEUTICALS SECTOR

blog article

Jul 31, 2017

Bronchodilators Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The fo...

Read More

Periodontitis Pipeline Drug Development Review H1 2017 PERIODONTITIS PIPELINE DRUG DEVELOPMENT REVIEW H1 2017

blog article

Jul 31, 2017

Periodontitis Pipeline Drug Development Review H1 2017 provides comprehensive information on the therapeutics under development for Periodontitis (Mouth and Dental Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and mo...

Read More

The Top 4 Most Expensive Drugs in the US are Hepatitis C Treatments THE TOP 4 MOST EXPENSIVE DRUGS IN THE US ARE HEPATITIS C TREATMENTS

blog article

Jul 28, 2017

It’s an issue that’s dominating headlines across the country: the price of prescription drugs. On one side, regulators, lawmakers and patients are calling for price caps and increased competition from generics to make runaway drug prices more affordable. On the other, pharmaceutical companies are ci...

Read More

People, Partners and Public Health: New Brand Showcases How USP Improves Health Around the World PEOPLE, PARTNERS AND PUBLIC HEALTH: NEW BRAND SHOWCASES HOW USP IMPROVES HEALTH AROUND THE WORLD

blog article

Jul 27, 2017

When people depend on the work you do for their health and wellbeing, you owe them your best. At USP, this responsibility is at the core of what we do. Today, two billion people more than 25% of the world’s population benefit from the quality standards we develop with our partners for how medicines,...

Read More

Drug Discovery: Common Enzyme Triggers Alzheimer’s & Parkinson’s DRUG DISCOVERY: COMMON ENZYME TRIGGERS ALZHEIMER’S & PARKINSON’S

blog article

Jul 27, 2017

The two neurodegenerative diseases also have discrete genetic and environmental risk factors. However, years of experimental research by neurologists has formulated the hypothesis that the two diseases start to look similar at the biochemical level. And the latest breakthrough serves as evidence for...

Read More

How do you get lower cost drugs? Give the FDA a bigger stick HOW DO YOU GET LOWER COST DRUGS? GIVE THE FDA A BIGGER STICK

blog article

Jul 27, 2017

President Teddy Roosevelt famously said of foreign policy, “speak softly, and carry a big stick.” This advice can also apply to regulation. It is important for regulators to tread lightly, but they should also have the tools to punish bad actors who are clearly manipulating the market. Regulation ca...

Read More

US Drug Prices And R&D, Take 2: A Reply To Grabowski And Manning, And To Light US DRUG PRICES AND R&D, TAKE 2: A REPLY TO GRABOWSKI AND MANNING, AND TO LIGHT

blog article

Jul 27, 2017

Recently we (along with Zachary Helms) published a Health Affairs Blog post refuting the pharmaceutical industry argument that the higher prices the industry charges in the US are justified because they are necessary to support research and development (R&D). Our analysis found that US taxpayers, pa...

Read More

How The Food And Drug Companies Ensure That We Get Sick And They Make Money HOW THE FOOD AND DRUG COMPANIES ENSURE THAT WE GET SICK AND THEY MAKE MONEY

blog article

Jul 26, 2017

Another reason for single-payer health care: The documentary What the Health shows how the lives and health of human beings are considered insignificant, and in many ways threatened, by the pursuit of profits in the meat and dairy and drug industries. The corporate disdain revealed by this film is n...

Read More

Myth vs. Fact: What’s Behind Drug Prices MYTH VS. FACT: WHAT’S BEHIND DRUG PRICES

blog article

Jul 25, 2017

The prices of many drugs continue to explode, and there’s still a lack of transparency in how these skyrocketing prices are set. So we’re fact-checking some of the pharmaceutical industry’s main arguments for why they have to charge hundreds of thousands of dollars for a course of ...

Read More

Is Drug Pricing Open and Honest? IS DRUG PRICING OPEN AND HONEST?

blog article

Jul 25, 2017

When it comes to drug prices, we keep hearing the same refrain from the pharmaceutical industry. Drugmakers have long argued they set prices to recoup their research and development costs and to invest in new therapies.

Read More

Using Prodrug Nanoparticles for Drug Delivery in Cancer Treatment USING PRODRUG NANOPARTICLES FOR DRUG DELIVERY IN CANCER TREATMENT

blog article

Jul 25, 2017

Nanoparticles have attracted wide attention in developing novel formulations to carry anticancer agents. One of the unique properties of a nanoparticle is the small particle size (generally in the range of 30–300 nm), which can easily penetrate the leaky blood vessels in the solid tumors and therefo...

Read More

Issues with Detecting Counterfeit Drugs ISSUES WITH DETECTING COUNTERFEIT DRUGS

blog article

Jul 25, 2017

The high reimbursement costs of medicines due to the higher R&D risks have attracted a massive chain of drug racketeers that sell spurious medicines at prices too good to believe. Even legitimate pharmaceutical supply chains, including community and online pharmacies, haven’t been spared by adulteri...

Read More

The Expanded Access Navigator – Helping Patients In Need of Potentially Life-Saving Drug Treatments THE EXPANDED ACCESS NAVIGATOR – HELPING PATIENTS IN NEED OF POTENTIALLY LIFE-SAVING DRUG TREATMENTS

blog article

Jul 24, 2017

Patients with serious or immediately life-threatening diseases or conditions who have no comparable or satisfactory alternative therapy and who seek access to potentially life-saving investigational drugs will have another option to guide them through the process – thanks to the launch today of a ne...

Read More

Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey POLICY CONDITIONS MAKE OR BREAK LEADERS IN BIOPHARMACEUTICAL INNOVATION: PRELIMINARY RESULTS FROM THE 2017 BCI SURVEY

blog article

Jul 24, 2017

In a world of global investment flows, securing a larger portion of the $150 billion invested per year by the research-based biopharmaceutical industry is anyone’s game. The 2017 results of the annual Biopharmaceutical Competitiveness & Investment (BCI) Survey, previewed at the International BIO Con...

Read More

Refining Value in Pharma REFINING VALUE IN PHARMA

blog article

Jul 21, 2017

In every facet of life, the concept of value is at play. Individuals make their own assessment of value and that shapes a host of decisions from what to buy and where to buy it. For drugs, the difference is often that the individual needs to rely on someone else’s assessment.

Read More

Orphan Diseases Or Population Health? Policy Choices Drive Venture Capital Investments ORPHAN DISEASES OR POPULATION HEALTH? POLICY CHOICES DRIVE VENTURE CAPITAL INVESTMENTS

blog article

Jul 21, 2017

The US exhibits a remarkable pipeline of biopharmaceutical innovation, with 170 new drugs and biologics launched into the market between 2011 and 2015 and another 22 drugs approved in 2016. A striking feature of the pharmaceutical pipeline is the large percentage launched for the treatment of small ...

Read More

How technology can help government fight the war on drugs HOW TECHNOLOGY CAN HELP GOVERNMENT FIGHT THE WAR ON DRUGS

blog article

Jul 21, 2017

Earlier this month, the Nashville District Attorney completely retired charges against a man named Christopher Miller who was arrested in May by the city’s police for attempting to sell the botanical substance called kratom. The move brought renewed attention to this naturally occurring product that...

Read More

New PhRMA resources chock full of biopharma industry facts NEW PHRMA RESOURCES CHOCK FULL OF BIOPHARMA INDUSTRY FACTS

blog article

Jul 20, 2017

Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for 14 percent of total national health spending, with brands accounting for just half of this (7 percent)? O...

Read More

When Older Drugs are Better Drugs WHEN OLDER DRUGS ARE BETTER DRUGS

blog article

Jul 20, 2017

Bill’s world was a dangerous one. He believed that people could control his mind using devices similar to a TV remote. He was not sure who was his friend and who was his foe. I found him curled up in a hospital bed, afraid to step out of his room. As a young man with schizophrenia, he had previously...

Read More

Standardized Extractables Testing Protocol for Single-Use Systems in Biomanufacturing – Part 2 STANDARDIZED EXTRACTABLES TESTING PROTOCOL FOR SINGLE-USE SYSTEMS IN BIOMANUFACTURING – PART 2

blog article

Jul 18, 2017

The extractable testing information package to be provided by an SUS supplier is not intended to be passed directly to a regulatory agency without a process- and product-specific evaluation. Rather, the purpose of the information package is to allow the SUS end user to rigorously estimate the types ...

Read More

MaPP Revision for Publication of Drug Product Approval Information MAPP REVISION FOR PUBLICATION OF DRUG PRODUCT APPROVAL INFORMATION

blog article

Jul 17, 2017

The Manual of Policies and Procedures (MaPP) 4520.1 entitled Communicating Drug Approval Information, underwent revisions and the new revised MaPP was published today. While it’s current revision history notes the following change – “Decreased the time for webmaster to post change from three to two...

Read More

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know MANUFACTURING CONTROL STRATEGIES: WHAT PHARMACEUTICAL AND BIOTECH COMPANIES NEED TO KNOW

blog article

Jul 17, 2017

The flow of quality drug product onto the market relies upon controlled and consistent pharmaceutical manufacturing practices. While drug manufacturers use many methods to help them standardize their processes, inconsistencies often persist in pharmaceutical production from site-to-site and across m...

Read More

Data Integrity: A big challenge for big pharma DATA INTEGRITY: A BIG CHALLENGE FOR BIG PHARMA

blog article

Jul 14, 2017

Data underpins every decision in the pharmaceutical value chain – from production line optimization, through to quality control, quality assurance and batch release. Perhaps unsurprisingly then, the completeness and reliability of pharmaceutical data has long been of interest to regulatory authoriti...

Read More

Precise Medicines: Matching Patients with the Most Effective Drugs PRECISE MEDICINES: MATCHING PATIENTS WITH THE MOST EFFECTIVE DRUGS

blog article

Jul 14, 2017

Precision medicine is making us re-think the way we treat disease. Rather than selecting therapies based solely on the disease itself, doctors are increasingly considering the patient’s unique genomic and molecular make-up when determining treatment. Not long ago this wouldn’t have been an option, b...

Read More

How pharmacists can help people with learning disabilities HOW PHARMACISTS CAN HELP PEOPLE WITH LEARNING DISABILITIES

blog article

Jul 14, 2017

Pharmacy teams in community, primary care and acute hospital settings see many people with learning disabilities. You may not have attached that label to an individual, but you know that you need to use easy words and short sentences for this person, or take longer to show them how to take their med...

Read More

New! Decommissioning of Pharma Equipment & Facilities Guide NEW! DECOMMISSIONING OF PHARMA EQUIPMENT & FACILITIES GUIDE

blog article

Jul 13, 2017

On 15 June, ISPE announced the release of their latest publication, ISPE Good Practice Guide: Decommissioning of Pharmaceutical Equipment and Facilities. The Guide is intended to be a “one-stop-shop” for information to be used for decommissioning and disposal of assets ranging from a single system t...

Read More

Measuring the ROI of Digital Strategies Within a Pharmaceutical Marketing Plan MEASURING THE ROI OF DIGITAL STRATEGIES WITHIN A PHARMACEUTICAL MARKETING PLAN

blog article

Jul 13, 2017

Many life science teams pursue digital initiatives to enhance their existing pharmaceutical marketing plan. Using social media and other popular websites to convey product information gives teams the opportunity to reach a much wider audience than traditional methods. Although digital strategies pro...

Read More

Speeding up drug approvals could put patient health at risk SPEEDING UP DRUG APPROVALS COULD PUT PATIENT HEALTH AT RISK

blog article

Jul 12, 2017

During his first address to Congress in February, President Trump called for more rapid approval of drugs by the Food and Drug Administration (FDA), claiming that the agency has a “slow and burdensome approval process” that is keeping medicines from those in need. He also called for slashing regulat...

Read More

Ensuring Part 11 Compliance on the Road to Successful Drug Approvals ENSURING PART 11 COMPLIANCE ON THE ROAD TO SUCCESSFUL DRUG APPROVALS

blog article

Jul 11, 2017

In an age when virtually every industry is using solutions in the cloud; leveraging the Internet; adopting Internet of Things (IoT) technologies to gather insights; and automating many manufacturing tasks, the pharmaceutical industry is no exception.

Read More

The Future of Pharmaceuticals THE FUTURE OF PHARMACEUTICALS

blog article

Jul 11, 2017

The inter linking of medicine and technology is paving way for newer opportunities in , surgery, and health monitoring. Medicine is increasingly being interspersed with fields such as computer science, nanotechnology and biotechnology to give hybrid fields that are slowly taking over traditional pha...

Read More

Changes in the Medical Devices Regulation affect drug delivery devices CHANGES IN THE MEDICAL DEVICES REGULATION AFFECT DRUG DELIVERY DEVICES

blog article

Jul 10, 2017

Article 117 of the Medical Devices Regulation (MDR) (Regulation (EU) 2017/745) amends the Directive on medicinal products for human use (MPD) (Directive 2001/83/EC). This will significantly affect pharmaceutical manufacturers supplying drug delivery devices in combination with their medicinal produc...

Read More

Partner Spotlight: MilliporeSigma and Biopharma Recycling PARTNER SPOTLIGHT: MILLIPORESIGMA AND BIOPHARMA RECYCLING

blog article

Jul 10, 2017

Here at Triumvirate Environmental, we work with our partners in environmental, health, and safety to promote environmental protection and sustainable development. Today, we would like to focus on one of our life sciences partners who has gone above and beyond to put a focus on corporate responsibili...

Read More

Understanding Antibiotic Prescribing and Stewardship by General Dentists UNDERSTANDING ANTIBIOTIC PRESCRIBING AND STEWARDSHIP BY GENERAL DENTISTS

blog article

Jul 10, 2017

A recently published report by authors from the Centers for Disease Control and Prevention (CDC) states that in 2011, general dentists prescribed 10% of all antibiotics in the community. The authors state that not much is known about the specifics of antibiotic prescribing practices in dentistry. Th...

Read More

DSCSA – Guidance documents provided by the US Food and Drug Administration DSCSA – GUIDANCE DOCUMENTS PROVIDED BY THE US FOOD AND DRUG ADMINISTRATION

blog article

Jul 09, 2017

The US Food and Drug Administration (FDA) has published guidance documents to help MAHs and CMOs navigate the Drug Supply Chain Security Act (DSCSA). The first major DSCSA serialization deadline is drawing near. Indeed, as of November 2017, all prescription medicines destined for the American market...

Read More

Useful Technology or Marketing Gag? – Virtual Reality in Pharma and Biotech USEFUL TECHNOLOGY OR MARKETING GAG? – VIRTUAL REALITY IN PHARMA AND BIOTECH

blog article

Jul 07, 2017

Virtual reality is an unmistakable new trend in the pharma and biotech industries. Wikipedia defines it as “immersive multimedia or computer-simulated life” that “replicates an environment that simulates physical presence in places in the real world or imagined worlds.” What lies behind this rather ...

Read More

When doctors turn salespersons for little-known pharma companies WHEN DOCTORS TURN SALESPERSONS FOR LITTLE-KNOWN PHARMA COMPANIES

blog article

Jul 06, 2017

After delivery at a maternity and nursing home in Borivali, Mumbai, the patient’s husband was handed over a prescription by the doctor. The three medicines prescribed happened to be of a little-known Nagpur based pharma company and were priced much higher than the same ones produced by reputed...

Read More

We Talk About Patient-Centricity but Are We Actually Listening to Patients? WE TALK ABOUT PATIENT-CENTRICITY BUT ARE WE ACTUALLY LISTENING TO PATIENTS?

blog article

Jul 06, 2017

There was a time when a physician’s advice would go unchallenged by their patient. Before the internet, and the wealth of helpful – and sometimes harmful – health information that can be found there, patients had few resources outside the doctor’s office to help them fully understand their condition...

Read More

Storage of Reference and Retain Pharmaceutical Samples STORAGE OF REFERENCE AND RETAIN PHARMACEUTICAL SAMPLES

blog article

Jul 05, 2017

Reference samples are retained to fulfil two purposes; firstly, to provide a sample for analytical testing and secondly to provide a specimen of the fully finished product. They serve as a record of the batch of finished product or starting material and can be assessed in the event of, for example,...

Read More

Dealing With Vaccine Allergies DEALING WITH VACCINE ALLERGIES

blog article

Jul 04, 2017

However, the redeeming quality of a vaccine-triggered allergy is that it is temporary, which means most patients outgrow it within a matter of two to five. But these allergies and the myths surrounding them are often used to avoiding immunization altogether, which can have severe consequences for th...

Read More

Enforcement Date Rolled Back One Year for Elements of Drug Supply Chain Security Act ENFORCEMENT DATE ROLLED BACK ONE YEAR FOR ELEMENTS OF DRUG SUPPLY CHAIN SECURITY ACT

blog article

Jul 02, 2017

FDA Issued a guidance document titled “Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy” (here) late last week that described the FDA’s position on enforcement discretion of certain key provisions of the Act that were set to take effect on November 27, 201...

Read More

Forty Years of Drug Product Manufacturing Advances FORTY YEARS OF DRUG PRODUCT MANUFACTURING ADVANCES

blog article

Jul 02, 2017

Although the pharmaceutical industry is criticized for its slowness to accept change, it has made manufacturing improvements in the past decades in response to changes in drug delivery (e.g., multi-layer tablets and prefilled syringes); market demands for cost-efficiency and the flexibility to make ...

Read More

How to Know when to Toss your Prescription Drug or Refrigerate it HOW TO KNOW WHEN TO TOSS YOUR PRESCRIPTION DRUG OR REFRIGERATE IT

blog article

Jun 28, 2017

Check the label on any prescription you fill and chances are it will have a label with an expiration date, as well as instructions on whether to keep your drug out of sunlight, refrigerated or another instruction.  This information is designed to provide you with a date for when to discard your...

Read More

FDA Tackles Drug Competition to Improve Patient Access FDA TACKLES DRUG COMPETITION TO IMPROVE PATIENT ACCESS

blog article

Jun 28, 2017

The FDA is taking two new steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to ...

Read More

The Value of Drug–Drug Interaction Risk Assessments THE VALUE OF DRUG–DRUG INTERACTION RISK ASSESSMENTS

blog article

Jun 28, 2017

Should a drug candidate move on to pre-clinical and clinical trials? It’s a question that every pharmaceutical developer must face, and the earlier they can answer it, the better in terms of use of time and effort. There are many important things to consider when looking at the potential of a new co...

Read More

ALL THINGS PHARMACEUTICAL ALL THINGS PHARMACEUTICAL

blog article

Jun 27, 2017

The White House recently launched a task force aimed at addressing the nation’s opioid addiction crisis, headed by New Jersey Gov. Chris Christie.1 According to the U.S. Department of Health & Human Services, the majority of drug overdose deaths that occur today involve an opioid. Prescrip...

Read More

The Trend in Biosimilar Development and Recent FDA Guidance THE TREND IN BIOSIMILAR DEVELOPMENT AND RECENT FDA GUIDANCE

blog article

Jun 27, 2017

At the present time, the regulatory and drug development communities are adapting to a rising trend in biosimilar development in a number of therapeutic areas. The regulatory framework for biosimilars in the US is still evolving; the number of biosimilars approved by the FDA in 2015 was 1, this rose...

Read More

News Recap: The Myth of Drug Expiration Dates NEWS RECAP: THE MYTH OF DRUG EXPIRATION DATES

blog article

Jun 27, 2017

There has been speculation about the rising drug prices in our changing healthcare environment and how high the prices will actually go. Well, the trends are clear hospitals and patients are concerned about the jaw-dropping increases in drug prices. While the launching of these new medications with ...

Read More

Pharmaceuticals, printers and paintballs: when variability in excipient quality is and isn’t acceptable PHARMACEUTICALS, PRINTERS AND PAINTBALLS: WHEN VARIABILITY IN EXCIPIENT QUALITY IS AND ISN’T ACCEPTABLE

blog article

Jun 26, 2017

Regardless of whether it’s prescription or over-the-counter, the ingredients on a drug product label typically include one, maybe two, active pharmaceutical ingredients (APIs). The rest of the list is comprised of “inactive” ingredients (excipients) which in reality are far from inactive. Their func...

Read More

GMP audits & inspections in the pharmaceutical industry GMP AUDITS & INSPECTIONS IN THE PHARMACEUTICAL INDUSTRY

blog article

Jun 23, 2017

Valicare, a subsidiary of Bosch Packaging Technology, has supported customers in the pharmaceutical industry for many years as a specialist for GMP compliance services. Our experienced team of auditors offers comprehensive solutions for individual needs.

Read More

Using Your Nursing Training to Spot Potential Prescription Drug Interactions USING YOUR NURSING TRAINING TO SPOT POTENTIAL PRESCRIPTION DRUG INTERACTIONS

blog article

Jun 23, 2017

Although medicines are routinely used to make people feel significantly better, there are occasions in which prescriptions can have devastating effects. Most major drug interactions are known, enabling doctors and pharmacists to avoid prescribing medicines to patients that could cause harm when comb...

Read More

FDA Working to Lift Barriers to Generic Drug Competition FDA WORKING TO LIFT BARRIERS TO GENERIC DRUG COMPETITION

blog article

Jun 22, 2017

Too many patients are being priced out of the medicines they need. While FDA doesn’t have a direct role in drug pricing, we can take steps to help address this problem by facilitating increased competition in the market for prescription drugs through the approval of lower-cost, generic medicines. Ov...

Read More

PSP Publishes New Databases for Pharmacometrics & Systems Pharmacology PSP PUBLISHES NEW DATABASES FOR PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

blog article

Jun 21, 2017

Most people probably associate the disciplines of Pharmacometrics and Systems Pharmacology in the first instance mainly with modeling and simulation. However, decades ago computer scientists had already pointed out the “garbage-in-garbage-out” (GIGO) principle, emphasizing the reliance of modelers ...

Read More

The imminent fall of Big Pharma THE IMMINENT FALL OF BIG PHARMA

blog article

Jun 21, 2017

Last week, three Tennessee prosecutors filed a lawsuit against three major pharmaceutical manufacturers — Purdue Pharma, Mallinckrodt and Endo Pharmaceuticals — accusing them of using an intentionally misleading campaign about the addictive risks of opiates then pushing opiate prescriptions.

Read More

Long-term Care Transitions: Safe Geriatric Medication Practices after Hospitalization LONG-TERM CARE TRANSITIONS: SAFE GERIATRIC MEDICATION PRACTICES AFTER HOSPITALIZATION

blog article

Jun 19, 2017

It is one of the most talked about issues in healthcare. The population of the United States (and the world!) is aging. In 2010, 40 million Americans were age 65 and older, and that number is projected to swell to 88 million by 2050. For those of us working in geriatric medicine, the increasing olde...

Read More

What is the impact of GST (Goods and Service Tax) on Pharmaceutical Sector? WHAT IS THE IMPACT OF GST (GOODS AND SERVICE TAX) ON PHARMACEUTICAL SECTOR?

blog article

Jun 16, 2017

The GST facility is required to convey an incredible lift to the Pharma Franchise Companies in India by making the inventory network service proficient and diminishing the cost of assembling pharmaceutical items. As expense rates on GST have been reported. The vast majority of pharmaceutical items f...

Read More

A Tale of Two Anti-Ebola Drugs A TALE OF TWO ANTI-EBOLA DRUGS

blog article

Jun 16, 2017

Since April, cases of Ebola virus disease (EVD) have been reported in the Democratic Republic of Congo. As of June 6, there were eight probable and confirmed cases, which were associated with four deaths. Thanks to the rapid and effective response coordinated by the World Health Organization (WHO) a...

Read More

Investing in the Future of Precision Medicine INVESTING IN THE FUTURE OF PRECISION MEDICINE

blog article

Jun 14, 2017

In previous posts on this blog, our scientists have described the current state of precision medicine, particularly how it relates to companion diagnostics (CDx) and immuno-oncology. As an enterprise, we have been focused on this area of medicine essentially from the beginning, more than 20 years ag...

Read More

How the Pharma Industrial Internet impacts your label production process HOW THE PHARMA INDUSTRIAL INTERNET IMPACTS YOUR LABEL PRODUCTION PROCESS

blog article

Jun 13, 2017

Many pharmaceutical industry analysts have pointed to the Internet of Things (IoT) and the Pharma Industrial Internet as the keys to providing the transparency and traceability pharmaceutical manufacturers need to meet the ever-expanding array of serialization requirements and regulations, and to op...

Read More

The pharmaceutical industry is at risk from Brexit THE PHARMACEUTICAL INDUSTRY IS AT RISK FROM BREXIT

blog article

Jun 11, 2017

Despite numerous debates about the impact of Brexit, the pharmaceutical industry seems to be less eye-catching than other sectors like the manufacturing supply chain and financial services. However, pharmaceuticals are one of the EU’s most important and fastest-growing industries, and they benefit g...

Read More

HRA Pharma takes to social media to support its ellaOne brand HRA PHARMA TAKES TO SOCIAL MEDIA TO SUPPORT ITS ELLAONE BRAND

blog article

Jun 07, 2017

HRA Pharma has launched its emergency contraceptive brand on social media, setting up new UK-focused channels on for ellaOne on Facebook and Twitter. The Paris-headquartered pharma company hopes the move will help it ‘address the need for accurate online information’, while also breaking...

Read More

High Risk Drug Domestic and Foreign Drug Inspections – Get Ready HIGH RISK DRUG DOMESTIC AND FOREIGN DRUG INSPECTIONS – GET READY

blog article

Jun 07, 2017

After slogging through some of the FDA dashboards, I came across one that I felt was worthy of mention. The FDA’s Office of Regulatory Affairs (ORA) has apparently begun the process of scoring drug manufacturing establishments in their risk-based inspection program. The FDA has been talking about ri...

Read More

55 Drugs Still on FDA Shortage List 55 DRUGS STILL ON FDA SHORTAGE LIST

blog article

Jun 05, 2017

Despite great efforts by the FDA and the industry, there still are 55 different drug products under shortage on the FDA’s list (here). While the number of drugs on the shortage list is much lower than we have seen in the past (100+), there is still cause for concern as products move on and off the l...

Read More

Pfizer hikes prices on nearly 100 drugs: report PFIZER HIKES PRICES ON NEARLY 100 DRUGS: REPORT

blog article

Jun 02, 2017

U.S. pharmaceutical company Pfizer has raised prices on nearly 100 drugs in the country in 2017 by an average of twenty percent, according to the Financial Times. The drug company raised the prices of 91 drugs on Thursday, including Viagra and Lyric, with price increases between five and thirteen pe...

Read More

A critical opportunity to prevent prescription drug abuse A CRITICAL OPPORTUNITY TO PREVENT PRESCRIPTION DRUG ABUSE

blog article

Jun 02, 2017

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb recently cited addressing the opioid crisis as his highest priority. As someone who has spent the bulk of my career focused on issues related to substance abuse, including more than 10 years with PhRMA and prior to that almost 8 yea...

Read More

Ohio AG Sues Pharmaceutical Companies Over Opioid Epidemic OHIO AG SUES PHARMACEUTICAL COMPANIES OVER OPIOID EPIDEMIC

blog article

Jun 02, 2017

The state of Ohio took a stand against its crippling opioid epidemic Wednesday, filing a lawsuit against five leading pharmaceutical companies that make addictive painkillers. Ohio’s attorney general, Mike DeWine, accused the companies of “fueling” the opioid epidemic by intentionally misleading doc...

Read More

Pharmaceutical Product Hopping: A Proposed Framework For Antitrust Analysis PHARMACEUTICAL PRODUCT HOPPING: A PROPOSED FRAMEWORK FOR ANTITRUST ANALYSIS

blog article

Jun 01, 2017

Skyrocketing drug prices are in the news. Overnight price increases have riveted the attention of the public, media, and politicians of all stripes. But one reason for high prices has flown under the radar. When drug companies reformulate their product, switching from one version of a drug to anothe...

Read More

Enabling an Evidence-Based Approach to Pharmacovigilance and Safety ENABLING AN EVIDENCE-BASED APPROACH TO PHARMACOVIGILANCE AND SAFETY

blog article

May 31, 2017

Safety departments at Marketing Authorization Holders & Regulatory Authorities are under pressure from all sides. They must constantly stay on top of compliance while managing ever-increasing pharmacovigilance case processing volumes and at the same time elevate more strategic activities, including ...

Read More

Pharma Digitalisation: Challenges and opportunities in transforming the pharma industry PHARMA DIGITALISATION: CHALLENGES AND OPPORTUNITIES IN TRANSFORMING THE PHARMA INDUSTRY

blog article

May 31, 2017

Digitalisation is fundamentally changing the healthcare industry. The Pharma industry, as a core part of healthcare, is no exception to this. New technologies and innovations are already enabling pharma companies to improve medicine development and patient care.

Read More

The Falsified Medicines Directive (FMD) 2011/62/EU THE FALSIFIED MEDICINES DIRECTIVE (FMD) 2011/62/EU

blog article

May 30, 2017

Counterfeit drugs entering the European supply chain pose a significant health and safety threat to patients. Furthermore, the European Union Intellectual Property Office (EUIPO) estimates that the legitimate industry loses approximately €10 billion of revenue annually due to the presence of counter...

Read More

Could Prescription Drugs Be Amazon’s Newest Category? COULD PRESCRIPTION DRUGS BE AMAZON’S NEWEST CATEGORY?

blog article

May 30, 2017

What started out as “Earth’s Biggest Bookstore” in 1995 transitioned, in less than a decade, to become the source of “Earth’s Biggest Selection,” and today, according to the most recent annual report, seeks to be “Earth’s most customer-centric company.” Perhaps this “customer obsession,” as it’s des...

Read More

Why biosimilars are changing the pharmaceutical industry WHY BIOSIMILARS ARE CHANGING THE PHARMACEUTICAL INDUSTRY

blog article

May 26, 2017

We caught up with Celltrion Healthcare‘s Ho-ung Kim to find out how biosimilars cut costs, increase access to medicine and are ultimately changing the industry.

Read More

Mind the Gap: Best Practices in Clinical Pharmacology Gap Analysis MIND THE GAP: BEST PRACTICES IN CLINICAL PHARMACOLOGY GAP ANALYSIS

blog article

May 25, 2017

Do you get anxious about taking tests? Many people do because they want to show their best efforts. Submitting your New Drug Application (NDA) to the FDA can be thought of as the ultimate test of a drug program. Are you confident that you’ll have robust answers to the 40 different questions that the...

Read More

Early HTA developments in Japan offer some positives for the pharma industry EARLY HTA DEVELOPMENTS IN JAPAN OFFER SOME POSITIVES FOR THE PHARMA INDUSTRY

blog article

May 25, 2017

The Japanese pharmaceutical market has been an ideal environment for the industry thanks to minimal regulatory delays, favorable pricing and high reimbursement rates. In the near future, however, this market is poised to become more restrictive as the Japanese government feels the pressure of financ...

Read More

Pitching pharmacists’ value as providers in the face of a major focus on drug pricing PITCHING PHARMACISTS’ VALUE AS PROVIDERS IN THE FACE OF A MAJOR FOCUS ON DRUG PRICING

blog article

May 24, 2017

Last week, APhA Senior Vice President of Pharmacy Practice and Government Affairs Stacie Maass and I joined a small group for a meeting with U.S. Department of Health and Human Services Secretary Tom Price. He wanted our input on how to address high drug prices. We know that pharmacists are not the ...

Read More

Pharmaceutical company to expand in Virginia PHARMACEUTICAL COMPANY TO EXPAND IN VIRGINIA

blog article

May 23, 2017

A pharmaceutical company from India is expanding its Virginia operation thanks in part to state incentives. Gov. Terry McAuliffe on Monday announced that Granules India will spent $35 million to expand its operation in Fairfax County. The governor said the state beat out New Jersey for the project a...

Read More

Re-Inventing R&D for Precision Medicine RE-INVENTING R&D FOR PRECISION MEDICINE

blog article

May 22, 2017

Precision medicine first emerged in the late ‘90s. But it was the completion of the Human Genome Project in 2003 that really opened up a world of opportunity in this area because it became possible to test patients for certain biomarkers that could help match patients to more tailored and appropriat...

Read More

Medicines are not luxury goods MEDICINES ARE NOT LUXURY GOODS

blog article

May 20, 2017

I must admit I had been somewhat skeptical about the “WHO Fair Pricing Forum” held last week in Amsterdam. There were multiple reasons for my apprehension. One concern was clearly that the notion of “fair” is pretty much in the eye of the beholder, another was that none of the 300 expected participa...

Read More

Scientists turn plant cells into efficient pharmaceutical factories SCIENTISTS TURN PLANT CELLS INTO EFFICIENT PHARMACEUTICAL FACTORIES

blog article

May 18, 2017

For the first time, researchers have developed a plant-based way to make pharmaceutical proteins that offers both rapid production and highly controlled conditions.

Read More

Behind the numbers: The pharmaceutical industry and global health BEHIND THE NUMBERS: THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

blog article

May 17, 2017

The most indisputable of all facts on global health is that we’re living longer and healthier lives than ever, and in an era of continuous health improvement.

Read More

Cloud-based Biotech: Managing Data for All Stages of Drug Development CLOUD-BASED BIOTECH: MANAGING DATA FOR ALL STAGES OF DRUG DEVELOPMENT

blog article

May 16, 2017

When it comes to developing new biotech therapies, strategic data management is more important than ever. Sponsors are challenged with integrating multiple data types in different formats collected at various stages of the drug development process including drug discovery, clinical trials and into c...

Read More

Catalent to Manufacture Lexicon Pharmaceuticals CATALENT TO MANUFACTURE LEXICON PHARMACEUTICALS' ORPHAN DRUG XERMELO

blog article

May 15, 2017

Catalent Pharma Solutions has welcomed FDA’s approval of Lexicon Pharmaceuticals’ orphan drug, Xermelo (telotristat ethyl), for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.

Read More

PMG-MAN unveils initiatives to exploit pharmaceutical industry’s potential PMG-MAN UNVEILS INITIATIVES TO EXPLOIT PHARMACEUTICAL INDUSTRY’S POTENTIAL

blog article

May 11, 2017

In a bid to address concerns in the nation’s pharmaceutical industry, Pharmaceutical Manufacturers Group of Manufacturers Association of Nigeria (PMG-MAN) has concluded plans to hold a forum to explore initiatives that will aid local manufacturing of medical commodities through policy changes, impro...

Read More

How Technology Is Speeding up the Drug Development Process HOW TECHNOLOGY IS SPEEDING UP THE DRUG DEVELOPMENT PROCESS

blog article

May 10, 2017

On average, it takes up to 10 years and $2.6 billion to bring a new drug to market, according to data collected by the Tufts Center for the Study of Drug Development. This includes both the drugs that successfully make it to market about 12 percent and those that fail at some point between initial d...

Read More

​Can “Affordable Medicines” become a reality for Ukraine? ​CAN “AFFORDABLE MEDICINES” BECOME A REALITY FOR UKRAINE?

blog article

May 10, 2017

A recent survey, “Cost(less) Medicine”, commissioned by the United States Agency for International Development (USAID) and conducted by the Patients of Ukraine charity, highlighted some of the major anomalies encountered within the current Ukrainian healthcare system. In a country which promises fre...

Read More

Overcoming Resistance to Precision Medicines OVERCOMING RESISTANCE TO PRECISION MEDICINES

blog article

May 10, 2017

Precision medicines, which target specific subgroups of patients bearing particular mutations or symptoms, have demonstrated astounding efficacies and have had great success in areas with limited treatment options. However, just because a precision medicine works for a patient at the onset of treatm...

Read More

Risk Evaluation and Mitigation Strategies (REMS): Why Should Pharmacists Care in 2017 and Beyond? RISK EVALUATION AND MITIGATION STRATEGIES (REMS): WHY SHOULD PHARMACISTS CARE IN 2017 AND BEYOND?

blog article

May 09, 2017

Heads up! Risk Evaluation and Mitigation Strategies, or REMS, have been referenced in a number of recent industry discussions and could present significant challenges to the practice and business of pharmacy over the next several years.

Read More

Points to Ponder When Defining a Non-clinical Pharmacology Strategy for Topical Drug Product Development POINTS TO PONDER WHEN DEFINING A NON-CLINICAL PHARMACOLOGY STRATEGY FOR TOPICAL DRUG PRODUCT DEVELOPMENT

blog article

May 09, 2017

Your project team is tasked with developing a topical semisolid product for a dermatological disease. The site of action for this dermal disease is thought to be at the.

Read More

Enter the EPR 21 Awards at eprawards.com now! ENTER THE EPR 21 AWARDS AT EPRAWARDS.COM NOW!

blog article

May 09, 2017

In our 21st anniversary year we are celebrating the wealth of innovation, excellence, and cutting-edge science in our industry, and want to recognise individuals, companies and institutions for their outstanding achievements and endeavours.

Read More

BID ADIEU TO MEDICARE’S EXPENSIVE SPECIALTY DRUG TIER? BID ADIEU TO MEDICARE’S EXPENSIVE SPECIALTY DRUG TIER?

blog article

May 08, 2017

Medicare drug plans are increasingly placing more of their life-or-death drugs on their specialty tiers and that’s causing some concern.

Read More

Avoiding the Risks of Being Wrong in Drug Discovery AVOIDING THE RISKS OF BEING WRONG IN DRUG DISCOVERY

blog article

May 05, 2017

In a recent case study featuring a mid-market biopharma company, a pre-clinical research leader explains that in order to avoid the risks of being wrong when investigating potential new molecules and validating methods he needs reliable, up to date and comprehensive scientific information.

Read More

Measuring the Value of Prescription Drugs MEASURING THE VALUE OF PRESCRIPTION DRUGS

blog article

May 04, 2017

One strategy for addressing the national outrage over drug pricing is to shift the discussion from “pay-per-pill” to outcomes-based pricing linked to how well a medicine improves patient health and reduces cost of treatment. Pharma companies are looking to justify prices by tapping payer data syste...

Read More

A recap of the Medical Device Packaging & Labeling Summit A RECAP OF THE MEDICAL DEVICE PACKAGING & LABELING SUMMIT

blog article

May 03, 2017

Last week, medical device manufacturers from across the U.S. came together to discuss the constantly changing world of labeling at Q1 Productions’ 6th Semi-Annual Medical Device Packaging and Labeling Summit.

Read More

At $800 Million, Costly New Drug Developments Demand Consistency AT $800 MILLION, COSTLY NEW DRUG DEVELOPMENTS DEMAND CONSISTENCY

blog article

May 03, 2017

According to information provided in the Congressional Budget Office’s 2006 study, Research and Development in the Pharmaceutical Industry, it costs pharmaceutical companies an average of 12 years and $800 million dollars to create and bring to market a drug that is based on a new molecular entity (...

Read More

Austria: Hastily implemented legal changes hit pharma industry AUSTRIA: HASTILY IMPLEMENTED LEGAL CHANGES HIT PHARMA INDUSTRY

blog article

May 03, 2017

A legal amendment implemented pushed through Austria’s parliament in late March introduces a series of changes unfavourable to producers of originators and generics. Tensions between the pharmaceutical industry and the social security institutions in Austria are high again after the implementation ...

Read More

Orphan Drug Transporters: Therapeutic Targets Identified with New Technology ORPHAN DRUG TRANSPORTERS: THERAPEUTIC TARGETS IDENTIFIED WITH NEW TECHNOLOGY

blog article

May 03, 2017

A brighter future in the field of pharmaceutical sciences depends, in part, on the consistent discovery of novel targets and delivery modalities. Dr. Marilyn E. Morris’ lab contributes to this paradigm by characterizing novel drug transporters in order to better understand their role in human physio...

Read More

Which Antioxidant is Right for Your Nutraceutical Product? WHICH ANTIOXIDANT IS RIGHT FOR YOUR NUTRACEUTICAL PRODUCT?

blog article

May 03, 2017

Despite their best efforts to eat a balanced diet, consumers are increasingly aware that they may not be getting all the micronutrients necessary to maintain good health. For decades, consumers have been turning to dietary supplements and nutraceuticals to support their healthy lifestyle.

Read More

LAWMAKERS TROUBLED BY MEDICAID PATIENT ABUSE LAWMAKERS TROUBLED BY MEDICAID PATIENT ABUSE

blog article

May 03, 2017

Medicaid provides care for some of the most vulnerable patients in the country, but recent government investigations have uncovered troubling reports of patient abuse and outright fraud.

Read More

DRUG, DEVICE INDUSTRIES, PATIENT GROUPS DIFFER ON OFF-LABEL COMMUNICATIONS DRUG, DEVICE INDUSTRIES, PATIENT GROUPS DIFFER ON OFF-LABEL COMMUNICATIONS

blog article

May 03, 2017

The drug and medical device industries want the FDA to allow them to give more information to payers and health-care professionals about off-label, or unapproved, uses of their products to help them make decisions.

Read More

Biosimilars: the future of Pharma? An interview with Boehringer Ingelheim BIOSIMILARS: THE FUTURE OF PHARMA? AN INTERVIEW WITH BOEHRINGER INGELHEIM

blog article

May 03, 2017

With biosimilars expected to account for 10% of the total biologics market by 2020, we caught up with Boehringer Ingelheim’s Senior VP and Head of Therapeutic Area Biosimilars.

Read More

A New Strategy for Overcoming Immunogenicity A NEW STRATEGY FOR OVERCOMING IMMUNOGENICITY

blog article

May 02, 2017

Unwanted immune response towards a therapeutic protein is a clinical complication that could compromise the safety and efficacy of the therapy.

Read More

What is the cost of drug development? WHAT IS THE COST OF DRUG DEVELOPMENT?

blog article

May 02, 2017

According to a 2014 study by the Tufts Center for the Study of Drug Development (TCSDD), the cost of developing a new drug, from research and development (R&D) to marketing approval, is approximately $2.9 billion.

Read More